Psychology and Neuroscience
Arts & Sciences
Duke University
| |
Faculty Database Psychology and Neuroscience Arts & Sciences Duke University |
|
| HOME > Arts & Sciences > pn > Faculty | Search Help Login |
|
| Publications of John F. Curry :chronological alphabetical combined listing:
%% Journal Articles
@article{fds358373,
Author = {Curry, JF and Kaminer, Y and Goldston, DB and Chan, G and Wells, KC and Burke, RH and Inscoe, AB and Meyer, AE and Cheek,
SM},
Title = {Adaptive Treatment for Youth With Substance Use and
Depression: Early Depression Response and Short-term
Outcomes.},
Journal = {J Am Acad Child Adolesc Psychiatry},
Volume = {61},
Number = {4},
Pages = {508-519},
Year = {2022},
Month = {April},
url = {http://dx.doi.org/10.1016/j.jaac.2021.07.807},
Abstract = {OBJECTIVE: To investigate prevalence and predictors of early
depression response (EDR) in adolescents with substance use
and depression receiving cognitive-behavioral therapy (CBT)
for substance use and to test the efficacy of supplemental
CBT targeting depression (CBT-D) for non-EDR adolescents in
an adaptive treatment approach. METHOD: At 2 sites, 95
youths (ages 14-21, mean [SD] = 17.4 [1.8]) with alcohol or
cannabis use and depressive symptoms received up to 12
sessions of CBT for substance use over 14 weeks. Assessments
were at baseline and weeks 4, 9, and 14. The Children's
Depression Rating Scale-Revised was the primary depression
measure, with a reduction of 50% or more on this scale at
week 4 defining EDR. The primary substance use outcomes of
alcohol use, heavy alcohol use, and cannabis use frequency
were assessed via interview report on the Alcohol
Consumption Questionnaire and the Drug Checklist. Urinalysis
provided a secondary measure of cannabis use. Non-EDR
adolescents were randomly assigned to supplemental CBT-D or
enhanced treatment as usual (ETAU). RESULTS: Thirty-five
adolescents (37%; 95% CI, 27%-47%) demonstrated EDR. Fewer
days of cannabis use (odds ratio 0.977; 95% CI, 0.961-0.992)
and absence of conduct disorder (odds ratio 0.149; 95% CI,
0.031-0.716) predicted EDR. Frequency of drinking (F1,82 =
11.09, η2 = 0.119, p = .001), heavy drinking (F1,82 =
19.91, η2 = 0.195, p < .0001), and cannabis use
(F1,220 = 35.01, η2 = 0.137, p < .001) decreased over
time for EDR, CBT-D, and ETAU adolescents, with EDR
adolescents evidencing earlier lower cannabis use (F2,220 =
4.16, η2 = 0.036, p = .0169). Negative (clean) urine
screens increased over time (F1,219 = 5.10, η2 = 0.023,
p = .0249). Comparison of CBT-D and ETAU indicated that
depression significantly decreased over time in both groups
(F1,48 = 64.20, η2 = 0.572, p < .001), with no advantage
for CBT-D. CONCLUSION: Approximately one-third of
adolescents with substance use and depression attain EDR
during substance use treatment. Less frequent cannabis use
facilitates depression response. The relatively small sample
may have precluded identification of additional EDR
predictors. CLINICAL TRIAL REGISTRATION INFORMATION:
Treatment for Teens With Alcohol Abuse and Depression;
https://clinicaltrials.gov/; NCT02227589.},
Doi = {10.1016/j.jaac.2021.07.807},
Key = {fds358373}
}
@article{fds359587,
Author = {Liu, Q and Martin, NC and Findling, RL and Youngstrom, EA and Garber, J and Curry, JF and Hyde, JS and Essex, MJ and Compas, BE and Goodyer, IM and Rohde, P and Stark, KD and Slattery, MJ and Forehand, R and Cole,
DA},
Title = {Hopelessness and depressive symptoms in children and
adolescents: An integrative data analysis.},
Journal = {J Abnorm Psychol},
Volume = {130},
Number = {6},
Pages = {594-607},
Year = {2021},
Month = {August},
url = {http://dx.doi.org/10.1037/abn0000667},
Abstract = {Although hopelessness has been linked to depression for
centuries, the diagnostic criteria for depression are
inconsistent with regard to the status of hopelessness. Most
research on hopelessness and depression has focused on
adults. The current study examined this relation in children
and adolescents. Integrative data analyses with a pooled
sample (N = 2466) showed that clinical levels of
hopelessness multiplied the odds of having a clinical
diagnosis of depression 10-fold. Conversely, not having
clinical levels of hopelessness multiplied the odds of
endorsing no clinical level of depressive symptoms 28-fold.
Moreover, results differed by levels of depression: (a)
among youths with clinical levels of depression,
hopelessness was associated with six depressive symptoms;
(b) among youths without clinical levels of depression,
hopelessness was associated with nine depressive symptoms.
We found that hopelessness helps to explain the
heterogeneity of depressive presentations. Our finding
supports the consideration of hopelessness in the diagnosis
(if not treatment and prevention) of depression in children
and adolescents. (PsycInfo Database Record (c) 2021 APA, all
rights reserved).},
Doi = {10.1037/abn0000667},
Key = {fds359587}
}
@article{fds347363,
Author = {Curry, JF and Shepherd-Banigan, M and Van Voorhees and E and Wagner, HR and Kelley, ML and Strauss, J and Naylor, J and Veterans Affairs
Mid-Atlantic MIRECC Women Veterans Work Group, and Veterans
Affairs Mid-Atlantic MIRECC Work Group},
Title = {Sex differences in predictors of recurrent major depression
among current-era military veterans.},
Journal = {Psychol Serv},
Volume = {18},
Number = {2},
Pages = {275-284},
Year = {2021},
Month = {May},
url = {http://dx.doi.org/10.1037/ser0000397},
Abstract = {Although major depressive disorder (MDD) is a frequent
diagnosis among women seeking care in the Veterans Health
Administration, little is known about its course. For
example, recurrence of MDD and its predictors have been
investigated in civilians, but not among female veterans.
Because female veterans differ from their civilian
counterparts and from male veterans on demographic
variables, including race, ethnicity, marital status, and
educational level, it is important to identify factors
affecting MDD course within this population. We investigated
frequency and correlates of recurrent MDD among female
veterans and their male counterparts. From a postdeployment
research registry of 3,247 participants (660 women and 2,587
men), we selected those with a current episode of MDD (141
women and 462 men). For each sex, we compared those
diagnosed with recurrent MDD with those experiencing a
single episode on demographics, comorbid diagnoses, family
history of mental illness, traumatic experiences, combat
exposure, and social support. In contrast to findings in
most civilian samples, recurrent MDD was significantly more
frequent in female (70.2%) than in male (45.2%) depressed
veterans, χ²(1) = 26.96, p < .001. In multivariable
analyses, recurrence among women was associated with greater
experiences of childhood abuse and more trauma during
military service and with lower rates of posttraumatic
stress disorder. Among men, recurrence was associated with
older age, family history of psychiatric hospitalization,
more postmilitary trauma, and lifetime anxiety disorder and
with lower likelihood of war zone deployment. Trauma was
associated with recurrence in both sexes, but the features
of traumatic events differed in women and men. (PsycInfo
Database Record (c) 2021 APA, all rights
reserved).},
Doi = {10.1037/ser0000397},
Key = {fds347363}
}
@article{fds351496,
Author = {Doyle, O and Weller, BE and Goldston, DB and Breland-Noble, AM and Estroff, SE and Daniel, SS and Curry, JF and Wells,
KC},
Title = {Coping in the Aftermath of Youth's Suicidal Behaviors: A
Comparison of Black Mothers and White Mothers},
Journal = {Family Relations},
Volume = {70},
Number = {1},
Pages = {77-89},
Year = {2021},
Month = {February},
url = {http://dx.doi.org/10.1111/fare.12484},
Abstract = {Objective: To better understand Black mothers' and White
mothers' qualitative reactions to their adolescents'
hospitalizations due to suicide attempts. Background:
Caregivers of youth with suicidal behaviors play a vital
role in youth's subsequent treatment and recovery. Yet
little attention has been paid to how they are affected by
youth's psychiatric hospitalizations or how their reactions
may be influenced by race. Method: Twenty Black mothers
(Mage = 42.50; SD = 8.48) and 20 White mothers
(Mage = 44.85; SD = 6.86) were randomly selected from
data originally collected for a larger longitudinal, mixed
method, multisite study. Data analysis was informed by
grounded theory methodology. Results: Four themes emerged
from the data: mothers' emotional distress; mothers' coping,
needs, and supports; mothers' perceived need for increased
monitoring; and improved mother–child relationships.
Conclusions: Black mothers and White mothers largely had
similar reactions to youth's hospitalizations; however,
nuanced differences also were noted regarding how they
described their experiences and what they emphasized.
Implications: During discharge planning, mothers need
additional support (beyond referrals) in their roles as
caregivers and for their own coping. Additional clinical and
research implications are discussed.},
Doi = {10.1111/fare.12484},
Key = {fds351496}
}
@article{fds359063,
Author = {Goldston, DB and Curry, JF and Wells, KC and Kaminer, Y and Daniel, SS and Esposito-Smythers, C and Doyle, O and Sapyta, J and Tunno, AM and Heilbron, NC and Roley-Roberts, M},
Title = {Feasibility of an Integrated Treatment Approach for Youth
with Depression, Suicide Attempts, and Substance Use
Problems.},
Journal = {Evid Based Pract Child Adolesc Ment Health},
Volume = {6},
Number = {2},
Pages = {155-172},
Year = {2021},
url = {http://dx.doi.org/10.1080/23794925.2021.1888664},
Abstract = {Depression, suicidal behaviors and substance use problems
frequently co-occur, and treatment for youth with these
co-occurring problems is often fragmented and challenging.
An integrated cognitive-behavioral treatment approach that
builds upon a relapse prevention framework and applies
common core skills, language, and approach for treating
these related problems may be clinically beneficial.
Following a description of the integrated approach, we
present results of a pilot trial (n = 13) to examine the
acceptability and feasibility of the Cognitive-Behavioral
Therapy - Relapse Prevention (CBT-RP) intervention plus
enhanced treatment as usual (TAU) compared to enhanced TAU
alone. The feasibility of the CBT-RP + TAU intervention was
reflected by high rates of retention (86%). The
acceptability was reflected in positive evaluations
regarding the helpfulness of the intervention by adolescents
and families. The majority of youth in both CBT-RP + TAU and
TAU alone groups evidenced reductions in depression and
suicide ideation from study entry to Week 20. Patterns of
reduction were more consistent, however, for youth receiving
CBT-RP + TAU, and reductions were slower to emerge for some
youth receiving TAU alone. Reductions in alcohol and
marijuana problems were similar, but half of the youth in
TAU alone (and none in the CBT-RP + TAU group) had emergency
department visits related to psychiatric crises or substance
related problems. These findings, although based on a small
sample, underscore the feasibility and acceptability of an
integrated cognitive-behavioral relapse prevention approach
for youth with depression, suicide attempt histories, and
substance use problems.},
Doi = {10.1080/23794925.2021.1888664},
Key = {fds359063}
}
@article{fds352042,
Author = {Meyer, AE and Curry, JF},
Title = {Moderators of Treatment for Adolescent Depression.},
Journal = {J Clin Child Adolesc Psychol},
Volume = {50},
Number = {4},
Pages = {486-497},
Year = {2021},
url = {http://dx.doi.org/10.1080/15374416.2020.1796683},
Abstract = {Objective: This brief report reviews the literature on
moderators of treatment for adolescent depression. Treatment
moderators can help to guide the process of personalizing
intervention to individual patient characteristics.Method:
We conducted a systematic search in PsycInfo and PubMed. We
also reviewed references of previous reviews and searched
for moderator analyses conducted secondary to published
efficacy studies.Results: We review 27 studies that address
the following categories of moderators: demographics,
severity indices, comorbidity, contextual factors, history
of abuse or trauma, and cognition and coping. We found
limited evidence that demographic, contextual, or cognitive
variables consistently moderated treatment for adolescent
depression. There was some indication of moderation by
race/ethnicity, presence of some comorbid disorders, greater
depression severity, and a history of trauma.Conclusion: Our
review found inconsistent findings across studies, likely
due to the strong impact of predictors relative to
moderators and limited statistical power. More research
using innovative statistical approaches is necessary before
treatment tailoring can be an empirically-based
process.},
Doi = {10.1080/15374416.2020.1796683},
Key = {fds352042}
}
@article{fds351215,
Author = {Arias, AJ and Hammond, CJ and Burleson, JA and Kaminer, Y and Feinn, R and Curry, JF and Dennis, ML},
Title = {Temporal dynamics of the relationship between change in
depressive symptoms and cannabis use in adolescents
receiving psychosocial treatment for cannabis use
disorder.},
Journal = {J Subst Abuse Treat},
Volume = {117},
Pages = {108087},
Year = {2020},
Month = {October},
url = {http://dx.doi.org/10.1016/j.jsat.2020.108087},
Abstract = {AIMS: Cannabis use disorder (CUD) and depression frequently
co-occur in youth. How depressive symptoms change over the
course of CUD treatment and how they impact substance use
treatment outcomes is unknown. In the current study, we
examine the temporal relationships between cannabis use and
depression in adolescents receiving evidence-based
treatments for CUD as part of a multisite clinical trial.
DESIGN: Six hundred adolescents (age 12-18) with a CUD were
randomly assigned to substance use treatment from one of
five evidence-based psychosocial interventions. We assessed
self-reported cannabis use frequency and depressive symptoms
at baseline (BL) and again at 3-, 6-, 9, and 12-months. A
bivariate latent change model assessed bidirectional effects
of baseline levels and time-lagged changes in depressive
symptoms and cannabis use on depression and cannabis use
outcomes. FINDINGS: Depressive symptoms (72%) and major
depressive disorder (MDD) (18%) were common at BL. Both
depression and cannabis use decreased over time and change
in cannabis use was significantly associated with change in
depressive symptoms (b = 1.22, p = .003). Time-lag
analyses showed that within-subject change in depression
(from one time point to the next) was predicted by previous
depression (b = -0.71, p < .001) but not cannabis use
(p = .068), and change (decrease) in cannabis use was
predicted by previous (greater) depressive symptoms
(b = -1.47, p < .001) but not cannabis use (p = .158),
respectively. CONCLUSION: These findings indicate an
enduring relationship between decreasing cannabis use and
decreasing depression among adolescents lasting for 9-months
after receiving psychosocial interventions for CUD. The
presence of depressive symptoms did not appear to interfere
with substance use treatment or attenuate improvements in
cannabis use frequency. A decrease in cannabis use was not
contingent upon a reduction in depressive symptoms. These
findings are limited by the possibility of regression to the
mean for both cannabis use and depressive symptoms, and the
lack of a nonintervention control group.},
Doi = {10.1016/j.jsat.2020.108087},
Key = {fds351215}
}
@article{fds350346,
Author = {Zhou, X and Teng, T and Zhang, Y and Del Giovane and C and Furukawa, TA and Weisz, JR and Li, X and Cuijpers, P and Coghill, D and Xiang, Y and Hetrick, SE and Leucht, S and Qin, M and Barth, J and Ravindran, AV and Yang, L and Curry, J and Fan, L and Silva, SG and Cipriani, A and Xie,
P},
Title = {Comparative efficacy and acceptability of antidepressants,
psychotherapies, and their combination for acute treatment
of children and adolescents with depressive disorder: a
systematic review and network meta-analysis.},
Journal = {Lancet Psychiatry},
Volume = {7},
Number = {7},
Pages = {581-601},
Year = {2020},
Month = {July},
url = {http://dx.doi.org/10.1016/S2215-0366(20)30137-1},
Abstract = {BACKGROUND: Depressive disorders are common in children and
adolescents. Antidepressants, psychotherapies, and their
combination are often used in routine clinical practice;
however, available evidence on the comparative efficacy and
safety of these interventions is inconclusive. Therefore, we
sought to compare and rank all available treatment
interventions for the acute treatment of depressive
disorders in children and adolescents. METHODS: We did a
systematic review and network meta-analysis. We searched
PubMed, Embase, the Cochrane Central Register of Controlled
Trials, Web of Science, PsycINFO, ProQuest, CINAHL, LiLACS,
international trial registries, and the websites of
regulatory agencies for published and unpublished randomised
controlled trials from database inception until Jan 1, 2019.
We included placebo-controlled and head-to-head trials of 16
antidepressants, seven psychotherapies, and five
combinations of antidepressant and psychotherapy that are
used for the acute treatment of children and adolescents
(≤18 years old and of both sexes) with depressive disorder
diagnosed according to standard operationalised criteria.
Trials recruiting participants with treatment-resistant
depression, bipolar disorder, psychotic depression,
treatment duration of less than 4 weeks, or an overall
sample size of fewer than ten patients were excluded. We
extracted data following a predefined hierarchy of outcome
measures, and assessed risk of bias and certainty of
evidence using validated methods. Primary outcomes were
efficacy (change in depressive symptoms) and acceptability
(treatment discontinuation due to any cause). We estimated
summary standardised mean differences (SMDs) or odds ratios
(ORs) with credible intervals (CrIs) using network
meta-analysis with random effects. This study was registered
with PROSPERO, number CRD42015020841. FINDINGS: From
20 366 publications, we included 71 trials (9510
participants). Depressive disorders in most studies were
moderate to severe. In terms of efficacy, fluoxetine plus
cognitive behavioural therapy (CBT) was more effective than
CBT alone (-0·78, 95% CrI -1·55 to -0·01) and
psychodynamic therapy (-1·14, -2·20 to -0·08), but not
more effective than fluoxetine alone (-0·22, -0·86 to
0·42). No pharmacotherapy alone was more effective than
psychotherapy alone. Only fluoxetine plus CBT and fluoxetine
were significantly more effective than pill placebo or
psychological controls (SMDs ranged from -1·73 to -0·51);
and only interpersonal therapy was more effective than all
psychological controls (-1·37 to -0·66). Nortriptyline
(SMDs ranged from 1·04 to 2·22) and waiting list (SMDs
ranged from 0·67 to 2·08) were less effective than most
active interventions. In terms of acceptability, nefazodone
and fluoxetine were associated with fewer dropouts than
sertraline, imipramine, and desipramine (ORs ranged from
0·17 to 0·50); imipramine was associated with more
dropouts than pill placebo, desvenlafaxine, fluoxetine plus
CBT, and vilazodone (2·51 to 5·06). Most of the results
were rated as "low" to "very low" in terms of confidence of
evidence according to Confidence In Network Meta-Analysis.
INTERPRETATION: Despite the scarcity of high-quality
evidence, fluoxetine (alone or in combination with CBT)
seems to be the best choice for the acute treatment of
moderate-to-severe depressive disorder in children and
adolescents. However, the effects of these interventions
might vary between individuals, so patients, carers, and
clinicians should carefully balance the risk-benefit profile
of efficacy, acceptability, and suicide risk of all active
interventions in young patients with depression on a
case-by-case basis. FUNDING: National Key Research and
Development Program of China.},
Doi = {10.1016/S2215-0366(20)30137-1},
Key = {fds350346}
}
@article{fds337454,
Author = {Donoho, CJ and LeardMann, C and O'Malley, CA and Walter, KH and Riviere,
LA and Curry, JF and Adler, AB},
Title = {Depression among military spouses: Demographic, military,
and service member psychological health risk
factors.},
Journal = {Depress Anxiety},
Volume = {35},
Number = {12},
Pages = {1137-1144},
Year = {2018},
Month = {December},
url = {http://dx.doi.org/10.1002/da.22820},
Abstract = {BACKGROUND: More than a decade of war has strained service
members and their families and the psychological health of
military spouses is a concern. This study uses data from the
largest study of military families in the United States to
examine the demographic, military-specific, and service
member mental health correlates of probable diagnosis of
major depressive disorder (MDD) among military spouses.
METHODS: Data were from service member-spouse dyads from all
branches of the U.S. military. Demographic and
military-specific factors were assessed using administrative
personnel records and survey data. RESULTS: Of the 9,038
spouses, 4.9% had a probable diagnosis of MDD. In unadjusted
models, spouses of service members who deployed and
experiencecd combat-related events, were enlisted, had a
probable posttraumatic stress disorder (PTSD) diagnosis, or
screened positive for alcohol misuse were more likely to
screen positive for MDD. In adjusted models, only spouses
married to enlisted service members or those with PTSD had
increased risk for MDD. Other demographic and
military-related factors associated with MDD in spouses
included less educational attainment, unemployment, having
four or more children, and having prior military service
(although not currently serving in the military) in the
adjusted models. CONCLUSIONS: Findings characterize
demographic, military, and service member psychological
health factors that are associated with depression among
military spouses. These findings imply that deployment alone
may not negatively affect military spouses, but rather it
may be the mental health impact on the service member,
especially PTSD that increases the odds for MDD among
military spouses.},
Doi = {10.1002/da.22820},
Key = {fds337454}
}
@article{fds336065,
Author = {Curry, JF and Kiser, LJ and Fernandez, PE and Elliott, AV and Dowling,
LVM},
Title = {Development and initial piloting of a measure of
post-deployment parenting reintegration experiences},
Journal = {Professional Psychology: Research and Practice},
Volume = {49},
Number = {2},
Pages = {159-166},
Publisher = {American Psychological Association (APA)},
Year = {2018},
Month = {April},
url = {http://dx.doi.org/10.1037/pro0000185},
Abstract = {Each phase of the deployment cycle poses challenges to
military parents and children, with the post-deployment
family reintegration period requiring returning military
parents to resume such roles as direct caretaking and child
discipline. Although veterans often report concerns about
this domain of reintegration, existing measures permit only
limited assessment of their parenting experiences. The
authors initiated development of a self-report checklist to
improve such assessment through two pilot studies. In the
first, they generated a 30-item checklist of positive and
challenging veteran parenting experiences, by interviewing
nine clinicians experienced in assessment or intervention
with veterans. In the second, 20 male veterans (mean age =
40.5 years) rated each parenting item based on their
experiences during post-deployment family reintegration.
They also indicated whether they had experienced any of 11
possible personal problems during this period and completed
a family functioning measure. Results indicated that
checklist items were relevant for the returning parents,
that positive parenting experiences were endorsed by a
higher percentage of veterans than challenging experiences,
and that challenging experiences were associated with
several personal problems and poorer family functioning.
Further psychometric testing with larger, more
representative samples of male and female veterans is
needed, to establish the validity and utility of the
measure.},
Doi = {10.1037/pro0000185},
Key = {fds336065}
}
@article{fds328869,
Author = {Meyer, AE and Curry, JF},
Title = {Pathways from anxiety to stressful events: An expansion of
the stress generation hypothesis.},
Journal = {Clin Psychol Rev},
Volume = {57},
Pages = {93-116},
Publisher = {Elsevier},
Year = {2017},
Month = {November},
url = {http://dx.doi.org/10.1016/j.cpr.2017.08.003},
Doi = {10.1016/j.cpr.2017.08.003},
Key = {fds328869}
}
@article{fds327307,
Author = {Shepherd-Banigan, M and Kelley, ML and Katon, JG and Curry, JF and Goldstein, KM and Brancu, M and Wagner, HR and Fecteau, TE and VA
Mid-Atlantic MIRECC Women Veterans Workgroup, and VA
Mid-Atlantic MIRECC Workgroup, and Van Houtven,
CH},
Title = {Paternal history of mental illness associated with
posttraumatic stress disorder among veterans.},
Journal = {Psychiatry Research},
Volume = {256},
Pages = {461-468},
Year = {2017},
Month = {October},
url = {http://dx.doi.org/10.1016/j.psychres.2017.06.053},
Abstract = {This study examined the association between parent and
family reported history of non-PTSD mental illness (MI),
PTSD specifically, and substance use problems, and
participant clinical diagnosis of PTSD. Participants were
drawn from the US Department of Veterans Affairs
Mid-Atlantic Mental Illness Research, Education and Clinical
Center (MIRECC) Post-Deployment Mental Health (PDMH) study
(n = 3191), an ongoing multi-site cohort study of US
Afghanistan and Iraq conflict era veterans. Participants who
recalled a father history of PTSD had a 26-percentage point
higher likelihood of meeting criteria for PTSD; while
participants reporting any family history of PTSD had a
15-percentage point higher probability of endorsing symptoms
consistent with PTSD. Mother history of substance use
problems was associated with Veteran current PTSD, but
results were sensitive to model specification. Current PTSD
was not associated with family/parent history of non-PTSD
mental illness, mother history of PTSD, or family/father
history of substance use problems. Family history of PTSD
may increase PTSD risk among veterans exposed to trauma,
particularly when a father history is reported. Knowledge of
family history could improve clinical decision-making for
trauma-exposed individuals and allow for more effective
targeting of programs and clinical services.},
Doi = {10.1016/j.psychres.2017.06.053},
Key = {fds327307}
}
@article{fds300118,
Author = {Peters, AT and Jacobs, RH and Feldhaus, C and Henry, DB and Albano, AM and Langenecker, SA and Reinecke, MA and Silva, SG and Curry,
JF},
Title = {Trajectories of Functioning Into Emerging Adulthood
Following Treatment for Adolescent Depression.},
Journal = {J Adolesc Health},
Volume = {58},
Number = {3},
Pages = {253-259},
Year = {2016},
Month = {March},
ISSN = {1054-139X},
url = {http://dx.doi.org/10.1016/j.jadohealth.2015.09.022},
Abstract = {PURPOSE: It is well established that empirically supported
treatments reduce depressive symptoms for most adolescents;
however, it is not yet known whether these interventions
lead to sustained improvements in global functioning. The
goal of this study is to assess the clinical characteristics
and trajectories of long-term psychosocial functioning among
emerging adults who have experienced adolescent-onset major
depressive disorder. METHODS: Global functioning was
assessed using the Clinical Global Assessment Scale for
children (participants ≤18 years), the Global Assessment
of Functioning (participants ≥ 19 years) and the Health
of the Nation Outcome Scales for Adolescents among 196
adolescents who elected to complete 3.5 years of
naturalistic follow-up subsequent to their participation in
the Treatment for Adolescents with Depression Study. The
Treatment for Adolescents with Depression Study examined the
efficacy of cognitive behavior therapy, fluoxetine, and the
combination of cognitive behavior therapy and fluoxetine
(combination treatment) over the course of 36 weeks.
Mixed-effects regression models were used to identify
trajectories and clinical predictors of functioning over the
naturalistic follow-up. RESULTS: Global functioning and
achievement of developmental milestones (college,
employment) improved over the course of follow-up for most
adolescents. Depressive relapse, initial randomization to
the placebo group, and the presence of multiple psychiatric
comorbidities conferred risk for relatively poorer
functioning. CONCLUSIONS: Functioning generally improves
among most adolescents who have received empirically
supported treatments. However, the presence of recurrent
major depressive disorder and multiple psychiatric
comorbidities is associated with poorer functioning
trajectories, offering targets for maintenance treatment or
secondary prevention.},
Doi = {10.1016/j.jadohealth.2015.09.022},
Key = {fds300118}
}
@article{fds314974,
Author = {Curry, JF and Meyer, AE},
Title = {Can Less Yield More? Behavioral Activation for Adolescent
Depression},
Journal = {Clinical Psychology: Science and Practice},
Volume = {23},
Number = {1},
Pages = {62-65},
Publisher = {WILEY},
Year = {2016},
Month = {March},
ISSN = {0969-5893},
url = {http://dx.doi.org/10.1111/cpsp.12141},
Abstract = {The report by Ritschel et al. (2016) demonstrates that
Behavioral Activation (BA) has significant promise as an
effective intervention for adolescent major depression. At a
minimum, confirmation of this finding in controlled trials
would increase the available treatments for depression in
young people. BA may also be more attractive to adolescents,
especially younger adolescents, than models of
cognitive-behavior therapy (CBT) that place greater emphasis
on cognitive change. A more general attraction of BA is its
relative simplicity, in comparison with the CBT models used
in recent major trials, all of which involved multiple
skill-training modules. The theoretical basis of BA lends
itself to studies of mechanisms of therapeutic change, and
may also prove to be useful within a Research Domain
Criteria (RDoC) framework.},
Doi = {10.1111/cpsp.12141},
Key = {fds314974}
}
@article{fds300291,
Author = {Rush, CC and Curry, JF and Looney, JG},
Title = {Alcohol expectancies and drinking behaviors among college
students with disordered eating.},
Journal = {J Am Coll Health},
Volume = {64},
Number = {3},
Pages = {195-204},
Year = {2016},
ISSN = {0744-8481},
url = {http://dx.doi.org/10.1080/07448481.2015.1107837},
Abstract = {OBJECTIVE: The authors investigated binge drinking, alcohol
expectancies, and risky and protective drinking behaviors in
relation to disordered eating behaviors in male and female
college students. PARTICIPANTS: The full sample consisted of
7,720 undergraduate students, 18 to 22 years of age.
Drinking behaviors were analyzed in 4,592 recent drinkers.
METHODS: Participants anonymously completed a survey as part
of a universal alcohol abuse prevention program between
September 2007 and April 2008. RESULTS: Co-occurring
disordered eating behaviors and binge drinking characterized
17.1% of males and 19.0% of females. Rates of binge drinking
were higher in those with disordered eating behaviors.
Students with disordered eating behaviors also had more
positive and negative alcohol expectancies and engaged in
more risky and fewer protective drinking behaviors than
their counterparts. CONCLUSIONS: Students with disordered
eating behaviors have outcome expectancies and behavior
patterns associated with problematic drinking. These
findings may enhance prevention and intervention
programs.},
Doi = {10.1080/07448481.2015.1107837},
Key = {fds300291}
}
@article{fds300119,
Author = {Curry, JF},
Title = {Training implications of psychology's approach to conscience
clause cases},
Journal = {Training and Education in Professional Psychology},
Volume = {9},
Number = {4},
Pages = {275-278},
Publisher = {American Psychological Association (APA)},
Year = {2015},
Month = {November},
ISSN = {1931-3918},
url = {http://dx.doi.org/10.1037/tep0000102},
Abstract = {The Board of Education Virtual Working Group on Restrictions
Affecting Diversity Training has generated a thoughtful
approach to the challenge of conscience clauses. In this
commentary short-term and longer-term implications of their
publications are considered, as these might affect training
programs seeking to implement the Working Group tenets.
Among the short-term issues that need to be addressed by
faculty members in professional psychology training programs
are (a) whether to focus broadly or more narrowly in
policies and program statements, (b) how to define a minimal
level of competence in students' ability to work with
diverse clients, (c) how to provide effective supervision
when conflicts arise between a trainee's values and clinical
needs of diverse clients, and (d) how to disclose policy in
a manner likely to be understood by program applicants.
Among the longer-term implications of the Working Groups
statements are (a) how to reach a deeper understanding of
what is meant by diversity in clinical training, (b) how to
integrate the focus on differences with a developing
appreciation of common humanity, (c) how to base diversity
training and practice on psychological science, and (d) how
to reduce judgmental thinking while facilitating the growth
of clinical judgment.},
Doi = {10.1037/tep0000102},
Key = {fds300119}
}
@article{fds271707,
Author = {Kelley, ML and Brancu, M and Robbins, AT and D'Lima, GM and Strauss, JL and Curry, JF and Fairbank, JA and Runnals, J and VA Mid-Atlantic MIRECC
Women Veterans Workgroup and VA Mid-Atlantic MIRECC
Workgroup},
Title = {Drug use and childhood-, military- and post-military trauma
exposure among women and men veterans.},
Journal = {Drug Alcohol Depend},
Volume = {152},
Pages = {201-208},
Year = {2015},
Month = {July},
ISSN = {0376-8716},
url = {http://dx.doi.org/10.1016/j.drugalcdep.2015.03.038},
Abstract = {BACKGROUND: The current study was undertaken to examine
whether posttraumatic stress symptoms (PTSS) and depressive
symptoms mediated the association between trauma exposure
(combat-related trauma and non-combat traumas occurring
before, during, and after military service), and drug abuse
symptoms use among male and female veterans. METHODS:
Participants were 2304 (1851 male, 453 female) veterans who
took part in a multi-site research study conducted through
the Department of Veterans Affairs Mid-Atlantic Mental
Illness Research, Education and Clinical Center (VISN 6
MIRECC). Path analytic models were used to determine the
association between problematic past-year drug use and
combat-related and non-combat trauma experienced before,
during, or after the military and whether current
post-traumatic stress symptoms or depressive symptoms
mediated these associations. RESULTS: For both male and
female veterans, depressive symptoms significantly mediated
the effects of pre- and post-military trauma on drug abuse
symptoms. CONCLUSION: Mental health providers who work with
trauma-exposed Iraq and Afghanistan era veterans should
assess for drug use, depressive symptoms, and life-span
trauma (i.e., not only combat-related traumas) as part of a
thorough trauma-based assessment for both men and
women.},
Doi = {10.1016/j.drugalcdep.2015.03.038},
Key = {fds271707}
}
@article{fds271708,
Author = {Curry, JF},
Title = {Good news in the battle against military
suicide.},
Journal = {American Journal of Psychiatry},
Volume = {172},
Number = {5},
Pages = {406-407},
Year = {2015},
Month = {May},
ISSN = {0002-953X},
url = {http://dx.doi.org/10.1176/appi.ajp.2015.15020172},
Doi = {10.1176/appi.ajp.2015.15020172},
Key = {fds271708}
}
@article{fds271709,
Author = {Goldman, EE and Bauer, D and Newman, DL and Kalka, E and Lochman, JE and Silverman, WK and Jensen, PS and Curry, J and Stark, K and Wells, KC and Bannon, WM and Integrated Psychotheraphy Consortium},
Title = {A school-based post-Katrina therapeutic intervention.},
Journal = {Adm Policy Ment Health},
Volume = {42},
Number = {3},
Pages = {363-372},
Year = {2015},
Month = {May},
ISSN = {0894-587X},
url = {http://dx.doi.org/10.1007/s10488-014-0576-y},
Abstract = {The current study presents the implementation of a set of
school based interventions in a greater New Orleans school
district one year following Hurricane Katrina. The
interventions included adaptation and implementation of
evidence based treatments in a crisis situation with at-risk
youth which involved training and clinical challenges. 386
students found to have significant depressive and/or
disruptive disorder symptoms received treatment from the
School Therapeutic Enhancement Program (STEP). Further, a
district-wide mental health needs assessment of middle and
high school students (N = 11,861) screened for behavioral
and emotional difficulties at the beginning and end of the
school year provided a benchmark for community youth's
emotional and behavioral distress. High-need intervention
students demonstrated clinically significant lower levels of
emotional and behavioral problems, depression and
inattention in comparison to pre-treatment levels as
indicated by multiple informants (i.e., self, parent,
teacher). Self-reported distress levels were also lower than
screening group students at post-test. These findings
support the efficacy of a school-based intervention for
youth struggling with the aftereffects of a highly
disruptive natural disaster. Implications for utilizing a
flexible adaptation of an evidence-based training model
involving coaching and consultation are discussed.},
Doi = {10.1007/s10488-014-0576-y},
Key = {fds271709}
}
@article{fds271705,
Author = {Crosskey, LB and Curry, JF and Leary, MR},
Title = {Role Transgressions, Shame, and Guilt Among
Clergy},
Journal = {Pastoral Psychology},
Volume = {64},
Number = {6},
Pages = {783-801},
Publisher = {Springer Nature},
Year = {2015},
Month = {April},
ISSN = {0031-2789},
url = {http://dx.doi.org/10.1007/s11089-015-0644-6},
Abstract = {After committing an error or transgression, people may
experience shame (they feel badly about themselves) or guilt
(they feel badly about their action or inaction). This study
investigated the possibility that people experience more
shame in domains that are relevant to their self-concept and
that shame in these domains is more strongly associated with
distress. Work or vocation is one domain in which
self-concept is often entangled. For instance, many clergy
fail to differentiate between who they are and what they do
in their role as pastor, raising the question of whether
transgressions that are relevant to the pastoral role evoke
greater shame than transgressions in other domains. Across
two studies, seminary students generated scenarios involving
failures that clergy may experience in their role as clergy,
and seminarians and clergy rated their reactions to these
scenarios and completed a measure of burnout. Results
demonstrated that higher shame, both in ministry situations
and in secular situations, was associated with higher
negative affect among seminarians and less satisfaction and
more emotional exhaustion in ministry among clergy. Contrary
to expectations, clergy did not experience more ministry
shame than general shame, nor was ministry shame more
strongly associated with clergy burnout than was general
shame. Implications for the mental health of ministers are
explored.},
Doi = {10.1007/s11089-015-0644-6},
Key = {fds271705}
}
@article{fds271713,
Author = {Brenner, SL and Burns, BJ and Curry, JF and Silva, SG and Kratochvil,
CJ and Domino, ME},
Title = {Mental health service use among adolescents following
participation in a randomized clinical trial for
depression.},
Journal = {J Clin Child Adolesc Psychol},
Volume = {44},
Number = {4},
Pages = {551-558},
Year = {2015},
ISSN = {1537-4416},
url = {http://dx.doi.org/10.1080/15374416.2014.881291},
Abstract = {Major depressive disorder (MDD) is a common disorder among
adolescents. The Treatment for Adolescents with Depression
Study (TADS) was a randomized controlled trial to examine
the efficacy of fluoxetine and cognitive-behavioral therapy
(CBT), separately and together, compared with placebo, in
adolescents 12 to 17 years of age. The Survey of Outcomes
Following Treatment for Adolescent Depression (SOFTAD) was
designed as a naturalistic follow-up of participants in
TADS. The aims of the current analyses are to describe
mental health service use during the SOFTAD period. There
were 196 adolescents recruited from 12 TADS sites. The
Schedule for Affective Disorders and Schizophrenia for
School-Age-Children-Present and Lifetime Version was used
for clinical diagnoses. Participants completed a psychiatric
treatment log and the Child and Adolescent Services
Assessment to assess service use. 58% received psychotherapy
or nonstimulant psychotropic medication during SOFTAD. Youth
with recurrent MDD had higher rates of treatment compared to
youth without recurrent MDD (71% vs. 45%). However, nearly
one third of the adolescents in the study did not receive
treatment for a recurrent episode of depression. Service use
differed by gender for those with recurrent MDD, with female
participants (79%) receiving treatment at higher rates than
male participants (55%), although there was no significant
difference in depression severity between genders. Younger
participants with recurrent MDD had higher odds of receiving
psychotherapy. Use of psychotherapy and psychotropics
following recurrence of depression appears to be influenced
by age and gender. Even when youth respond well to
treatment, a sizeable percentage are likely to experience a
subsequent episode that may go untreated.},
Doi = {10.1080/15374416.2014.881291},
Key = {fds271713}
}
@article{fds271711,
Author = {Freeman, J and Sapyta, J and Garcia, A and Compton, S and Khanna, M and Flessner, C and FitzGerald, D and Mauro, C and Dingfelder, R and Benito,
K and Harrison, J and Curry, J and Foa, E and March, J and Moore, P and Franklin, M},
Title = {Family-based treatment of early childhood
obsessive-compulsive disorder: the Pediatric
Obsessive-Compulsive Disorder Treatment Study for Young
Children (POTS Jr)--a randomized clinical
trial.},
Journal = {Jama Psychiatry},
Volume = {71},
Number = {6},
Pages = {689-698},
Year = {2014},
Month = {June},
ISSN = {2168-622X},
url = {http://dx.doi.org/10.1001/jamapsychiatry.2014.170},
Abstract = {IMPORTANCE: Cognitive behavior therapy (CBT) has been
established as efficacious for obsessive-compulsive disorder
(OCD) among older children and adolescents, yet its effect
on young children has not been evaluated sufficiently.
OBJECTIVE: To examine the relative efficacy of family-based
CBT (FB-CBT) involving exposure plus response prevention vs
an FB relaxation treatment (FB-RT) control condition for
children 5 to 8 years of age. DESIGN, SETTING, AND
PARTICIPANTS: A 14-week randomized clinical trial (Pediatric
Obsessive-Compulsive Disorder Treatment Study for Young
Children [POTS Jr]) conducted at 3 academic medical centers
between 2006 and 2011, involving 127 pediatric outpatients 5
to 8 years of age who received a primary diagnosis of OCD
and a Children's Yale-Brown Obsessive Compulsive Scale total
score of 16 or higher. INTERVENTIONS: Participants were
randomly assigned to 14 weeks of (1) FB-CBT, including
exposure plus response prevention, or (2) FB-RT. MAIN
OUTCOMES AND MEASURES: Responder status defined as an
independent evaluator-rated Clinical Global
Impression-Improvement scale score of 1 (very much improved)
or 2 (much improved) and change in independent
evaluator-rated continuous Children's Yale-Brown Obsessive
Compulsive Scale total score. RESULTS Family-based CBT was
superior to FB-RT on both primary outcome measures. The
percentages of children who were rated as 1 (very much
improved) or 2 (much improved) on the Clinical Global
Impression-Improvement scale at 14 weeks were 72% for FB-CBT
and 41% for FB-RT. The effect size difference between FB-CBT
and FB-RT on the Clinical Global Impression-Improvement
scale was 0.31 (95% CI, 0.17-0.45). The number needed to
treat (NNT) with FB-CBT vs FB-RT was estimated as 3.2 (95%
CI, 2.2-5.8). The effect size difference between FB-CBT and
FB-RT on the Children's Yale-Brown Obsessive Compulsive
Scale at week 14 was 0.84 (95% CI, 0.62-1.06). CONCLUSIONS
AND RELEVANCE: A comprehensive FB-CBT program was superior
to a relaxation program with a similar format in reducing
OCD symptoms and functional impairment in young children
(5-8 years of age) with OCD. TRIAL REGISTRATION:
clinicaltrials.gov Identifier: NCT00533806.},
Doi = {10.1001/jamapsychiatry.2014.170},
Key = {fds271711}
}
@article{fds271716,
Author = {Becker, SJ and Curry, JF},
Title = {Testing the effects of peer socialization versus selection
on alcohol and marijuana use among treated
adolescents.},
Journal = {Subst Use Misuse},
Volume = {49},
Number = {3},
Pages = {234-242},
Year = {2014},
Month = {February},
ISSN = {1082-6084},
url = {http://dx.doi.org/10.3109/10826084.2013.824479},
Abstract = {This study examined the relative influence of peer
socialization and selection on alcohol and marijuana use
among 106 adolescents who received a brief intervention.
Adolescents were recruited between 2003 and 2007 and
followed for 12 months as part of a SAMHSA-funded study.
Cross-lagged panel models using four assessment points
examined the longitudinal relationship between adolescent
substance use and peer substance involvement separately for
alcohol and marijuana. Consistent with community studies,
there was evidence of both peer socialization and peer
selection for alcohol use, and only evidence of peer
selection for marijuana use. Implications for research and
intervention are discussed.},
Doi = {10.3109/10826084.2013.824479},
Key = {fds271716}
}
@article{fds271715,
Author = {Curry, JF and Hersh, J},
Title = {Development and Evolution of Cognitive Behavior Therapy for
Depressed Adolescents},
Journal = {Journal of Rational Emotive & Cognitive Behavior
Therapy},
Volume = {32},
Number = {1},
Pages = {15-30},
Publisher = {Springer Nature},
Year = {2014},
Month = {January},
ISSN = {0894-9085},
url = {http://dx.doi.org/10.1007/s10942-014-0180-9},
Abstract = {Since the 1980's cognitive behavior therapy (CBT) has been
developed and tested with adolescents experiencing
depression. Early studies demonstrated that CBT was more
effective than no intervention for young people with
depressive symptoms. Beginning in the 1990's CBT has been
proven to be efficacious for adolescents with diagnosed
depressive disorders, specifically Major Depressive Disorder
(MDD). A series of increasingly challenging and
methodologically rigorous trials showed that CBT was an
effective intervention for mild to moderate MDD, and
enhanced the benefits of anti-depressant medication, even
for those adolescents who had already failed to respond to
an initial medication. Simultaneously, some limitations of
CBT were suggested by these studies. Results of CBT alone
were not encouraging with severely depressed adolescents,
and the combination of CBT plus medication was not uniformly
supported. As CBT investigators worked with more
challenging, complex clinical cases, such as depressed
adolescents who were abusing substances or engaging in
suicidal or self-harm behaviors, standard components of CBT
were augmented by increased emphasis placed on emotion
regulation, safety planning, and by more intensive
outpatient treatment models. Newer developments include
"third wave" models, which have shown initial promise. ©
2014 Springer Science+Business Media New
York.},
Doi = {10.1007/s10942-014-0180-9},
Key = {fds271715}
}
@article{fds271719,
Author = {Curry, JF and Aubuchon-Endsley, N and Brancu, M and Runnals, JJ and VA
Mid-Atlantic Mirecc Women Veterans Research Workgroup, and VA
Mid-Atlantic Mirecc Registry Workgroup, and Fairbank,
JA},
Title = {Lifetime major depression and comorbid disorders among
current-era women veterans.},
Journal = {J Affect Disord},
Volume = {152-154},
Number = {1},
Pages = {434-440},
Year = {2014},
Month = {January},
ISSN = {0165-0327},
url = {http://www.ncbi.nlm.nih.gov/pubmed/24210623},
Abstract = {BACKGROUND: Most research on women veterans' mental health
has focused on postraumatic stress disorder (PTSD) or
reactions to military sexual trauma. Although depression is
also a frequent diagnosis among women veterans, little is
known about its characteristics, including comorbid
conditions and patterns of disorder onset. We investigated
lifetime diagnoses of major depressive disorder (MDD) and
comorbid conditions in a primarily treatment-seeking
research sample of male and female veterans to determine
frequency of lifetime MDD, comorbid disorders and their
temporal onset. METHOD: The 1700 veterans (346 women; 1354
men) completed diagnostic interviews as participants in a
research registry. Rates of and gender differences in
lifetime MDD and comorbid conditions (PTSD, other anxiety
disorders, substance use and eating disorders) were
calculated. We assessed the percentage of cases in which MDD
preceded the comorbid condition (primary onset MDD).
RESULTS: Lifetime MDD was frequent in this sample, and
significantly more common in women (46.5%) than in men
(36.3%). Gender differences in comorbidity were found for
anxiety and eating disorders (more common in women); and for
alcohol and nicotine use disorders (more common in men).
However, primary onset MDD was no more common among women
than among men, and was in neither case the predominant
pattern of comorbid lifetime disorder onset. LIMITATIONS:
The sample is not representative of all veterans, and
lifetime diagnoses were based on retrospective recall.
CONCLUSIONS: MDD usually follows the onset of other comorbid
disorders among women veterans, indicating the need to
assess for earlier lifetime disorders in veterans with
MDD.},
Doi = {10.1016/j.jad.2013.10.012},
Key = {fds271719}
}
@article{fds271710,
Author = {Hersh, J and Curry, JF and Kaminer, Y},
Title = {What is the impact of comorbid depression on adolescent
substance abuse treatment?},
Journal = {Subst Abus},
Volume = {35},
Number = {4},
Pages = {364-375},
Year = {2014},
ISSN = {0889-7077},
url = {http://dx.doi.org/10.1080/08897077.2014.956164},
Abstract = {BACKGROUND: Substance use disorders (SUDs) are among the
most common psychiatric diagnoses in adolescents. Some
research suggests that comorbid depression in adolescents
with SUD is associated with increased likelihood of alcohol
dependence, poorer social competence, and greater risk for
suicide attempts. However, little is known about how
depression influences adolescent substance abuse treatment
retention and outcomes. METHODS: This review aimed to
summarize the effects of comorbid depression on treatment
retention and outcomes across 13 adolescent SUD treatment
studies. RESULTS: RESULTS indicated that depression has a
mixed relationship with treatment retention and outcomes,
exerting a negative, positive, or nonsignificant effect
depending on aspects of the study. CONCLUSIONS: More
research needs to be done, particularly addressing the
potential mediators and moderators of the relationship
between depression and SUD outcomes. Importantly,
recognizing that the studies varied widely in hypotheses and
research methods, the field needs to develop more
standardized methods to allow for a clearer understanding of
the role of comorbid depression.},
Doi = {10.1080/08897077.2014.956164},
Key = {fds271710}
}
@article{fds271712,
Author = {Curry, JF},
Title = {Future directions in research on psychotherapy for
adolescent depression.},
Journal = {J Clin Child Adolesc Psychol},
Volume = {43},
Number = {3},
Pages = {510-526},
Year = {2014},
ISSN = {1537-4416},
url = {http://dx.doi.org/10.1080/15374416.2014.904233},
Abstract = {Research over the past 3 decades has shown that
psychotherapy can successfully address adolescent
depression. Cognitive behavioral models have been most
extensively and rigorously tested, with evidence also
supporting interpersonal psychotherapy and attachment-based
family therapy. However, the vast majority of studies have
focused on short-term treatment of depressive episodes, even
as evidence accumulates that depression is frequently a
recurring condition extending into adulthood. Moreover,
treatment studies indicate that better longer term outcomes
are attained by adolescents who respond earlier and more
completely to intervention. Given what has been learned to
date about adolescent depression treatment, future
psychotherapy research should adopt a longer term
perspective and focus on the following key challenges: (a)
preventing relapse and recurrent episodes, while improving
speed and thoroughness of initial treatment response; (b)
identifying the necessary treatment components and learning
processes that lead to successful and enduring recovery from
depression; (c) determining whether-and, if so, how-to
address comorbid disorders within depression treatment; (d)
addressing the dilemma of simplicity versus complexity in
treatment models. Given the relatively small number of
evidence-based treatment models, newer approaches warrant
investigation. These should be tested against existing
models and also compared to medication and combined
(psychotherapy plus medication) treatment. Advances in
technology now enable investigators to improve
dissemination, to conduct experimental psychotherapeutics
and to expand application of Internet-based interventions to
the goals of relapse and recurrence prevention.},
Doi = {10.1080/15374416.2014.904233},
Key = {fds271712}
}
@article{fds271714,
Author = {Jacobs, RH and Becker, SJ and Curry, JF and Silva, SG and Ginsburg, GS and Henry, DB and Reinecke, MA},
Title = {Increasing Positive Outlook Partially Mediates the Effect of
Empirically Supported Treatments on Depression Symptoms
Among Adolescents.},
Journal = {Journal of Cognitive Psychotherapy},
Volume = {28},
Number = {1},
Pages = {3-19},
Year = {2014},
ISSN = {0889-8391},
url = {http://dx.doi.org/10.1891/0889-8391.28.1.3},
Abstract = {Among adolescents there is evidence that cognitive change
partially mediates the effect of cognitive behavioral
therapy (CBT) on depression outcome. However, prior studies
have been limited by small samples, narrow measures of
cognition, and failure to compare cognitive change following
CBT to cognitive change following antidepressant medication.
This study examined whether change in four cognitive
constructs (cognitive distortions, cognitive avoidance,
positive outlook, and solution-focused thinking) mediated
change in depression severity in a sample of 291 adolescents
who participated in the Treatment for Adolescents with
Depression Study (TADS). TADS assessed the effects of CBT,
fluoxetine, and their combination on depression severity.
All three treatments were associated with change in the
cognitive constructs and combination treatment produced the
greatest change. Furthermore, change in the cognitive
constructs partially mediated change in depression severity
within all three treatments. Results implicated positive
outlook as the construct most associated with change in
depression severity over 36 weeks.},
Doi = {10.1891/0889-8391.28.1.3},
Key = {fds271714}
}
@article{fds271717,
Author = {Hersh, J and Curry, JF and Becker, SJ},
Title = {The Influence of Comorbid Depression and Conduct Disorder on
MET/CBT Treatment Outcome for Adolescent Substance Use
Disorders.},
Journal = {International Journal of Cognitive Therapy},
Volume = {6},
Number = {4},
Pages = {325-341},
Year = {2013},
Month = {December},
ISSN = {1937-1209},
url = {http://dx.doi.org/10.1521/ijct.2013.6.4.325},
Abstract = {Although depression and conduct disorder frequently co-occur
with substance use disorders (SUDs), few studies have
investigated the individual and interactive effects of these
conditions on SUD treatment outcome. Data were collected
from 90 adolescents aged 13-21 (M = 17.1, SD = 2.07) who
received a brief evidence-based intervention for SUD.
Hierarchical regressions assessed the relationship among
demographic variables, depression, conduct disorder, and two
substance use outcomes (frequency and problems) at two
intervals (three months, six months). Results revealed that
higher baseline substance use and lower socioeconomic status
significantly predicted higher substance problems and
frequency at three-months. At six months, higher three month
substance problems and lower depressive symptoms predicted
substance problems. In addition, an interaction indicated
that the effect of conduct disorder on substance problems
was greatest at lower levels of depression. Results are
discussed in the context of previous research indicating
mixed effects of depression on SUD treatment
outcome.},
Doi = {10.1521/ijct.2013.6.4.325},
Key = {fds271717}
}
@article{fds300120,
Author = {de Luise, C and Kolitsopoulos, F and Nieto, AE and Curry, JF and March,
JS},
Title = {Pediatric Pharmacoepidemiology Safety Study with Long-Term
Use of Sertraline: The SPRITES Study},
Journal = {Pharmacoepidemiology and Drug Safety},
Volume = {22},
Pages = {333-334},
Publisher = {WILEY-BLACKWELL},
Year = {2013},
Month = {October},
ISSN = {1053-8569},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334876101234&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
Key = {fds300120}
}
@article{fds225130,
Author = {J. Hersh and J.F. Curry and S.J. Becker},
Title = {The influence of comorbid depression and conduct disorder on
MET/CBT outcome for adolescent substance use
disorders},
Journal = {Journal of Cognitive Therapy},
Volume = {6},
Pages = {325-341},
Year = {2013},
Key = {fds225130}
}
@article{fds271721,
Author = {Cole, DA and Cho, S-J and Martin, NC and Youngstrom, EA and March, JS and Findling, RL and Compas, BE and Goodyer, IM and Rohde, P and Weissman,
M and Essex, MJ and Hyde, JS and Curry, JF and Forehand, R and Slattery,
MJ and Felton, JW and Maxwell, MA},
Title = {Are increased weight and appetite useful indicators of
depression in children and adolescents?},
Journal = {J Abnorm Psychol},
Volume = {121},
Number = {4},
Pages = {838-851},
Year = {2012},
Month = {November},
ISSN = {0021-843X},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311527700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92},
Abstract = {During childhood and adolescence, physiological,
psychological, and behavioral processes strongly promote
weight gain and increased appetite while also inhibiting
weight loss and decreased appetite. The Diagnostic and
Statistical Manual-IV (DSM-IV) treats both
weight-gain/increased-appetite and weight-loss/decreased-appetite
as symptoms of major depression during these developmental
periods, despite the fact that one complements typical
development and the other opposes it. To disentangle the
developmental versus pathological correlates of weight and
appetite disturbance in younger age groups, the current
study examined symptoms of depression in an aggregated
sample of 2307 children and adolescents, 47.25% of whom met
criteria for major depressive disorder. A multigroup,
multidimensional item response theory model generated three
key results. First, weight loss and decreased appetite
loaded strongly onto a general depression dimension; in
contrast, weight gain and increased appetite did not.
Instead, weight gain and increased appetite loaded onto a
separate dimension that did not correlate strongly with
general depression. Second, inclusion or exclusion of weight
gain and increased appetite affected neither the nature of
the general depression dimension nor the fidelity of major
depressive disorder diagnosis. Third, the general depression
dimension and the weight-gain/increased-appetite dimension
showed different patterns across age and gender. In child
and adolescent populations, these results call into question
the utility of weight gain and increased appetite as
indicators of depression. This has serious implications for
the diagnostic criteria of depression in children and
adolescents. These findings inform a revision of the DSM,
with implications for the diagnosis of depression in this
age group and for research on depression.},
Doi = {10.1037/a0028175},
Key = {fds271721}
}
@article{fds271732,
Author = {Barnard, LK and Curry, JF},
Title = {The Relationship of Clergy Burnout to Self-Compassion and
Other Personality Dimensions},
Journal = {Pastoral Psychology},
Volume = {61},
Number = {2},
Pages = {149-163},
Publisher = {Springer Nature},
Year = {2012},
Month = {April},
ISSN = {0031-2789},
url = {http://dx.doi.org/10.1007/s11089-011-0377-0},
Abstract = {Religious leaders often experience burnout, which is
characterized by emotional exhaustion and/or low
satisfaction. Clergy with high emotional exhaustion feel
drained and discouraged. Clergy with high satisfaction
report that the ministry gives purpose and meaning to their
lives. Hierarchichal regression was used to examine if
current clergy's desire to please others, guilt or shame
orientation, ability to be self-compassionate, and ability
to differentiate self from role uniquely predicted variation
in burnout. Although all personality dimensions explained
significant variation in emotional satisfaction when
examined individually, due to inter-correlations among
predictors only self-compassion was significant in the full
model. Higher self-compassion was also related to increased
satisfaction in ministry. Increasing self-compassion may
prevent clergy burnout. © 2011 Springer Science+Business
Media, LLC.},
Doi = {10.1007/s11089-011-0377-0},
Key = {fds271732}
}
@article{fds271733,
Author = {Becker, SJ and Stein, GL and Curry, JF and Hersh,
J},
Title = {Ethnic differences among substance-abusing adolescents in a
treatment dissemination project.},
Journal = {J Subst Abuse Treat},
Volume = {42},
Number = {3},
Pages = {328-336},
Year = {2012},
Month = {April},
ISSN = {0740-5472},
url = {http://dx.doi.org/10.1016/j.jsat.2011.08.007},
Abstract = {Despite evidence of ethnic differences in substance use
patterns among adolescents in community samples, clinical
studies have not found ethnic differences in posttreatment
outcomes. Prior clinical studies have been limited by small
samples, focus on broad treatment modalities, and lack of
consideration of important covariates. We investigated
ethnic differences in substance use frequency and problems
in a large sample of White (60%), African American (12%),
and Latino (28%) adolescents prior to and following an
evidence-based treatment. Participants included 4,502
adolescents (29% female), with ages 13-18 years, who
received Motivational Enhancement Therapy/Cognitive Behavior
Therapy 5 Sessions. At baseline, African American
adolescents demonstrated less frequent use, fewer problems,
and less comorbidity than Whites or Latinos. Consistent with
prior research, there were no ethnic differences in
substance use outcomes among assessment completers (71%)
when controlling for baseline differences. However, African
Americans, older adolescents, and males were less likely to
complete the posttreatment assessment. Implications for
clinical service and effectiveness research are
discussed.},
Doi = {10.1016/j.jsat.2011.08.007},
Key = {fds271733}
}
@article{fds271738,
Author = {Curry, J and Silva, S and Rohde, P and Ginsburg, G and Kennard, B and Kratochvil, C and Simons, A and Kirchner, J and May, D and Mayes, T and Feeny, N and Albano, AM and Lavanier, S and Reinecke, M and Jacobs, R and Becker-Weidman, E and Weller, E and Emslie, G and Walkup, J and Kastelic, E and Burns, B and Wells, K and March, J},
Title = {Onset of alcohol or substance use disorders following
treatment for adolescent depression.},
Journal = {J Consult Clin Psychol},
Volume = {80},
Number = {2},
Pages = {299-312},
Year = {2012},
Month = {April},
ISSN = {0022-006X},
url = {http://dx.doi.org/10.1037/a0026929},
Abstract = {OBJECTIVE: This study tested whether positive response to
short-term treatment for adolescent major depressive
disorder (MDD) would have the secondary benefit of
preventing subsequent alcohol use disorders (AUD) or
substance use disorders (SUD). METHOD: For 5 years, we
followed 192 adolescents (56.2% female; 20.8% minority) who
had participated in the Treatment for Adolescents with
Depression Study (TADS; TADS Team, 2004) and who had no
prior diagnoses of AUD or SUD. TADS initial treatments were
cognitive behavior therapy (CBT), fluoxetine alone (FLX),
the combination of CBT and FLX (COMB), or clinical
management with pill placebo (PBO). We used both the
original TADS treatment response rating and a more
restrictive symptom count rating. During follow-up,
diagnostic interviews were completed at 6- or 12-month
intervals to assess onset of AUD or SUD as well as MDD
recovery and recurrence. RESULTS: Achieving a positive
response to MDD treatment was unrelated to subsequent AUD
but predicted a lower rate of subsequent SUD, regardless of
the measure of positive response (11.65% vs. 24.72%, or
10.0% vs. 24.5%, respectively). Type of initial MDD
treatment was not related to either outcome. Prior to
depression treatment, greater involvement with alcohol or
drugs predicted later AUD or SUD, as did older age (for AUD)
and more comorbid disorders (for SUD). Among those with
recurrent MDD and AUD, AUD preceded MDD recurrence in 24 of
25 cases. CONCLUSION: Effective short-term adolescent
depression treatment significantly reduces the rate of
subsequent SUD but not AUD. Alcohol or drug use should be
assessed prior to adolescent MDD treatment and monitored
even after MDD recovery.},
Doi = {10.1037/a0026929},
Key = {fds271738}
}
@article{fds271720,
Author = {Simons, AD and Marti, CN and Rohde, P and Lewis, CC and Curry, J and March,
J},
Title = {Does homework "matter" in cognitive behavioral therapy for
adolescent depression?},
Journal = {Journal of Cognitive Psychotherapy},
Volume = {26},
Number = {4},
Pages = {390-404},
Publisher = {Springer Publishing Company},
Year = {2012},
Month = {January},
ISSN = {0889-8391},
url = {http://dx.doi.org/10.1891/0889-8391.26.4.390},
Abstract = {Objective: Examine the degree to which homework completion
is associated with various indices of clinical improvement
in adolescents with depression treated with cognitive
behavioral therapy (CBT) either as a monotherapy and in
combination with antidepressant medication. Method: This
study used data from the Treatment of Adolescents with
Depression Study (TADS), which compared the efficacy of CBT,
fluoxetine (FLX), the combination of CBT and FLX (COMB), and
a pill placebo (PBO; TADS Team, 2003, 2004, 2005). Current
analyses included only TADS participants in the CBT (n 5
111) or COMB (n 5 107) conditions. Analyses focused on the
relations between partial and full homework completion and a
dichotomized measure of clinical response, evaluator and
self-report ratings of depressive symptoms, hopelessness,
and suicidality. Results: Homework completion significantly
predicted clinical improvement, decrease in self-reported
hopelessness, suicidality, and depression-but not in
evaluator-rated depressive symptoms-in adolescents treated
with CBT only. These relationships were almost completely
absent in the COMB condition. The only significant COMB
finding was that partially completed homework was related to
decrease in hopelessness over time. Conclusions: These
findings suggest that the ability of therapists and clients
to collaboratively develop and complete between-session
assignments is associated with response to CBT, self-report
of severity of depressive symptoms, hopelessness, and
suicidality and may be integral to optimizing the effects of
CBT when delivered as a monotherapy. © 2012 Springer
Publishing Company.},
Doi = {10.1891/0889-8391.26.4.390},
Key = {fds271720}
}
@article{fds271730,
Author = {Cole, DA and Cai, L and Martin, NC and Findling, RL and Youngstrom, EA and Garber, J and Curry, JF and Hyde, JS and Essex, MJ and Compas, BE and Goodyer, IM and Rohde, P and Stark, KD and Slattery, MJ and Forehand,
R},
Title = {Structure and measurement of depression in youths: applying
item response theory to clinical data.},
Journal = {Psychol Assess},
Volume = {23},
Number = {4},
Pages = {819-833},
Year = {2011},
Month = {December},
ISSN = {1040-3590},
url = {http://dx.doi.org/10.1037/a0023518},
Abstract = {Our goals in this article were to use item response theory
(IRT) to assess the relation of depressive symptoms to the
underlying dimension of depression and to demonstrate how
IRT-based measurement strategies can yield more reliable
data about depression severity than conventional symptom
counts. Participants were 3,403 children and adolescents
from 12 contributing clinical and nonclinical samples; all
participants had received the Kiddie Schedule of Affective
Disorders and Schizophrenia for School-Aged Children.
Results revealed that some symptoms reflected higher levels
of depression and were more discriminating than others.
Furthermore, use of IRT-based information about symptom
severity and discriminability in the measurement of
depression severity was shown to reduce measurement error
and increase measurement fidelity.},
Doi = {10.1037/a0023518},
Key = {fds271730}
}
@article{fds271731,
Author = {Barnard, LK and Curry, JF},
Title = {Self-Compassion: Conceptualizations, Correlates, &
Interventions},
Journal = {Review of General Psychology},
Volume = {15},
Number = {4},
Pages = {289-303},
Publisher = {American Psychological Association (APA)},
Year = {2011},
Month = {December},
ISSN = {1089-2680},
url = {http://dx.doi.org/10.1037/a0025754},
Abstract = {Within American psychology, there has been a recent surge of
interest in self-compassion, a construct from Buddhist
thought. Self-compassion entails: (a) being kind and
understanding toward oneself in times of pain or failure,
(b) perceiving one's own suffering as part of a larger human
experience, and (c) holding painful feelings and thoughts in
mindful awareness. In this article we review findings from
personality, social, and clinical psychology related to
self-compassion. First, we define self-compassion and
distinguish it from other self-constructs such as
self-esteem, self-pity, and self-criticism. Next, we review
empirical work on the correlates of self-compassion,
demonstrating that self-compassion has consistently been
found to be related to well-being. These findings support
the call for interventions that can raise self-compassion.
We then review the theory and empirical support behind
current interventions that could enhance self-compassion
including compassionate mind training (CMT), imagery work,
the gestalt two-chair technique, mindfulness based stress
reduction (MBSR), dialectical behavior therapy (DBT), and
acceptance and commitment therapy (ACT). Directions for
future research are also discussed. © 2011 American
Psychological Association.},
Doi = {10.1037/a0025754},
Key = {fds271731}
}
@article{fds271729,
Author = {Becker, SJ and Curry, JF and Yang, C},
Title = {Factors that influence trajectories of change in frequency
of substance use and quality of life among adolescents
receiving a brief intervention.},
Journal = {J Subst Abuse Treat},
Volume = {41},
Number = {3},
Pages = {294-304},
Year = {2011},
Month = {October},
ISSN = {0740-5472},
url = {http://dx.doi.org/10.1016/j.jsat.2011.04.004},
Abstract = {This study aimed to identify factors influencing
trajectories of change in two outcome domains, frequency of
substance use and quality of life (QOL), among adolescents
receiving a brief evidence-based intervention. Participants
were 106 adolescents, aged 13 to 21 years, who met criteria
for a substance use disorder. The adolescents received a
five-session intervention and completed four assessments
over 12 months. Based upon a theoretical and empirical
review, five putative predictors were tested: gender, age,
severity of conduct disorder, severity of depression, and
peer substance involvement. Results of a parallel-process
latent growth curve model indicated that higher peer
substance involvement and conduct severity predicted higher
frequency of use at baseline, whereas higher peer substance
involvement and depression severity predicted poorer QOL at
baseline. Counter to predictions, higher depression severity
predicted greater improvements in QOL following substance
use treatment. The implications of baseline risk factors on
adolescents' response to intervention are
discussed.},
Doi = {10.1016/j.jsat.2011.04.004},
Key = {fds271729}
}
@article{fds271728,
Author = {Curry, JF},
Title = {Now that we have a strong building, let's add a few
floors},
Journal = {Clinical Psychology: Science and Practice},
Volume = {18},
Number = {2},
Pages = {178-181},
Publisher = {WILEY},
Year = {2011},
Month = {June},
ISSN = {0969-5893},
url = {http://dx.doi.org/10.1111/j.1468-2850.2011.01249.x},
Abstract = {The new review by Chorpita and colleagues (2011) indicates
an expanded number of evidence-based interventions for child
and adolescent disorders. Notably, some of the best new
treatments combine psychotherapy and medication. The new
review wisely includes promising interventions with emerging
or lower levels of empirical support. Overall, the evidence
base for child and adolescent interventions is broad and
strong. Future reviews should provide further
differentiation among interventions with higher levels of
support. Specifically, the notion of treatment equivalence
needs more rigorous justification, effect sizes should be
interpreted in the context of trial designs, and reviews
should emphasize indices of the quality of supportive
evidence. © 2011 American Psychological Association.
Published by Wiley Periodicals, Inc., on behalf of the
American Psychological Association.},
Doi = {10.1111/j.1468-2850.2011.01249.x},
Key = {fds271728}
}
@article{fds271737,
Author = {Curry, J and Silva, S and Rohde, P and Ginsburg, G and Kratochvil, C and Simons, A and Kirchner, J and May, D and Kennard, B and Mayes, T and Feeny,
N and Albano, AM and Lavanier, S and Reinecke, M and Jacobs, R and Becker-Weidman, E and Weller, E and Emslie, G and Walkup, J and Kastelic, E and Burns, B and Wells, K and March, J},
Title = {Recovery and recurrence following treatment for adolescent
major depression.},
Journal = {Arch Gen Psychiatry},
Volume = {68},
Number = {3},
Pages = {263-269},
Year = {2011},
Month = {March},
ISSN = {0003-990X},
url = {http://dx.doi.org/10.1001/archgenpsychiatry.2010.150},
Abstract = {CONTEXT: Major depressive disorder in adolescents is common
and impairing. Efficacious treatments have been developed,
but little is known about longer-term outcomes, including
recurrence. OBJECTIVES: To determine whether adolescents who
responded to short-term treatments or who received the most
efficacious short-term treatment would have lower recurrence
rates, and to identify predictors of recovery and
recurrence. DESIGN: Naturalistic follow-up study. SETTING:
Twelve academic sites in the United States. PARTICIPANTS:
One hundred ninety-six adolescents (86 males and 110
females) randomized to 1 of 4 short-term interventions
(fluoxetine hydrochloride treatment, cognitive behavioral
therapy, their combination, or placebo) in the Treatment for
Adolescents With Depression Study were followed up for 5
years after study entry (44.6% of the original Treatment for
Adolescents With Depression Study sample). MAIN OUTCOME
MEASURES: Recovery was defined as absence of clinically
significant major depressive disorder symptoms on the
Schedule for Affective Disorders and Schizophrenia for
School-Age Children-Present and Lifetime Version interview
for at least 8 weeks, and recurrence was defined as a new
episode of major depressive disorder following recovery.
RESULTS: Almost all participants (96.4%) recovered from
their index episode of major depressive disorder during the
follow-up period. Recovery by 2 years was significantly more
likely for short-term treatment responders (96.2%) than for
partial responders or nonresponders (79.1%) (P < .001) but
was not associated with having received the most efficacious
short-term treatment (the combination of fluoxetine and
cognitive behavioral therapy). Of the 189 participants who
recovered, 88 (46.6%) had a recurrence. Recurrence was not
predicted by full short-term treatment response or by
original treatment. However, full or partial responders were
less likely to have a recurrence (42.9%) than were
nonresponders (67.6%) (P = .03). Sex predicted recurrence
(57.0% among females vs 32.9% among males; P = .02).
CONCLUSIONS: Almost all depressed adolescents recovered.
However, recurrence occurs in almost half of recovered
adolescents, with higher probability in females in this age
range. Further research should identify and address the
vulnerabilities to recurrence that are more common among
young women.},
Doi = {10.1001/archgenpsychiatry.2010.150},
Key = {fds271737}
}
@article{fds271739,
Author = {Stein, GL and Curry, JF and Hersh, J and Breland-Noble, A and March, J and Silva, SG and Reinecke, MA and Jacobs, R},
Title = {Ethnic differences among adolescents beginning treatment for
depression.},
Journal = {Cultural Diversity & Ethnic Minority Psychology},
Volume = {16},
Number = {2},
Pages = {152-158},
Year = {2010},
Month = {April},
ISSN = {1099-9809},
url = {http://www.ncbi.nlm.nih.gov/pubmed/20438153},
Abstract = {This study examines ethnic/racial differences at the start
of treatment among participants in the Treatment for
Adolescents with Depression Study (TADS). African American
and Latino youth were compared to Caucasian youth on symptom
presentation and cognitive variables associated with
depression. Contrary to hypothesis, there were no
significant differences in symptom presentation as measured
by the interview-based items of the Children's Depression
Rating Scale--Revised (CDRS-R). However, African American
and Latino youth were both rated as demonstrating more
severe symptoms on the observational items of the CDRS-R
compared to Caucasian youth. In terms of cognitive variables
associated with depression, African Americans reported fewer
negative cognitive biases compared to Caucasians, but
cognitive biases were significantly correlated with
depression severity across ethnic groups.},
Doi = {10.1037/a0018666},
Key = {fds271739}
}
@article{fds271740,
Author = {Kratochvil, CJ and May, DE and Silva, SG and Madaan, V and Puumula, SE and Curry, JF and Walkup, J and Kepley, H and Vitiello, B and March,
JS},
Title = {Treatment response in depressed adolescents with and without
comorbid attention deficit/hyperactivity
disorder},
Journal = {Journal of Child and Adolescent Psychopharmacology},
Year = {2010},
Key = {fds271740}
}
@article{fds271725,
Author = {Reinecke, MA and Curry, JF and March, JS},
Title = {Findings from the Treatment for Adolescents with Depression
Study (TADS): what have we learned? What do we need to
know?},
Journal = {J Clin Child Adolesc Psychol},
Volume = {38},
Number = {6},
Pages = {761-767},
Year = {2009},
Month = {November},
url = {http://www.ncbi.nlm.nih.gov/pubmed/20183660},
Abstract = {This introduction to the special section on findings from
the Treatment for Adolescents with Depression Study provides
a review of the rationale for the study, its design, and
principal findings to date. Findings with regard to acute
effectiveness of alternative treatments, relapse,
recurrence, maintenance of gains, and the effects of
treatment on suicidal ideations and suicidal behavior are
reviewed. We conclude with a brief discussion of unresolved
clinical issues, including treatment resistance, management
of partial response, moderators and predictors of long-term
response, and mediators of clinical change. The articles of
the special section address a range of issues including
relations between cognitive factors associated with
depression, relations between maladaptive beliefs and
treatment response, cognitive mediators of therapeutic
improvement, relations between family conflict and treatment
response, and the economic costs of adolescent
depression.},
Doi = {10.1080/15374410903258991},
Key = {fds271725}
}
@article{fds271741,
Author = {Feeny, NC and Silva, SG and Reinecke, MA and McNulty, S and Findling,
RL and Rohde, P and Curry, JF and Ginsburg, GS and Kratochvil, CJ and Pathak, SM and May, DE and Kennard, BD and Simons, AD and Wells, KC and Robins, M and Rosenberg, D and March, JS},
Title = {An exploratory analysis of the impact of family functioning
on treatment for depression in adolescents.},
Journal = {J Clin Child Adolesc Psychol},
Volume = {38},
Number = {6},
Pages = {814-825},
Year = {2009},
Month = {November},
url = {http://www.ncbi.nlm.nih.gov/pubmed/20183665},
Abstract = {This article explores aspects of family environment and
parent-child conflict that may predict or moderate response
to acute treatments among depressed adolescents (N = 439)
randomly assigned to fluoxetine, cognitive behavioral
therapy, their combination, or placebo. Outcomes were Week
12 scores on measures of depression and global impairment.
Of 20 candidate variables, one predictor emerged: Across
treatments, adolescents with mothers who reported less
parent-child conflict were more likely to benefit than their
counterparts. When family functioning moderated outcome,
adolescents who endorsed more negative environments were
more likely to benefit from fluoxetine. Similarly, when
moderating effects were seen on cognitive behavioral therapy
conditions, they were in the direction of being less
effective among teens reporting poorer family
environments.},
Doi = {10.1080/15374410903297148},
Key = {fds271741}
}
@article{fds271742,
Author = {Jacobs, RH and Silva, SG and Reinecke, MA and Curry, JF and Ginsburg,
GS and Kratochvil, CJ and March, JS},
Title = {Dysfunctional attitudes scale perfectionism: a predictor and
partial mediator of acute treatment outcome among clinically
depressed adolescents.},
Journal = {J Clin Child Adolesc Psychol},
Volume = {38},
Number = {6},
Pages = {803-813},
Year = {2009},
Month = {November},
url = {http://www.ncbi.nlm.nih.gov/pubmed/20183664},
Abstract = {The effect of perfectionism on acute treatment outcomes was
explored in a randomized controlled trial of 439 clinically
depressed adolescents (12-17 years of age) enrolled in the
Treatment for Adolescents with Depression Study (TADS) who
received cognitive behavior therapy (CBT), fluoxetine, a
combination of CBT and FLX, or pill placebo. Measures
included the Children's Depression Rating Scale-Revised, the
Suicidal Ideation Questionnaire-Grades 7-9, and the
perfectionism subscale from the Dysfunctional Attitudes
Scale (DAS). Predictor results indicate that adolescents
with higher versus lower DAS perfectionism scores at
baseline, regardless of treatment, continued to demonstrate
elevated depression scores across the acute treatment
period. In the case of suicidality, DAS perfectionism
impeded improvement. Treatment outcomes were partially
mediated by the change in DAS perfectionism across the
12-week period.},
Doi = {10.1080/15374410903259031},
Key = {fds271742}
}
@article{fds271743,
Author = {Ginsburg, GS and Silva, SG and Jacobs, RH and Tonev, S and Hoyle, RH and Kingery, JN and Reinecke, MA and Curry, JF and March,
JS},
Title = {Cognitive measures of adolescent depression: unique or
unitary constructs?},
Journal = {J Clin Child Adolesc Psychol},
Volume = {38},
Number = {6},
Pages = {790-802},
Year = {2009},
Month = {November},
url = {http://www.ncbi.nlm.nih.gov/pubmed/20183663},
Abstract = {The factor structure of several self-report questionnaires
assessing depression-relevant cognitions frequently employed
in clinical research was examined in a sample of 390
adolescents (M age = 14.54; 216 girls; 74% Caucasian) with
current major depressive disorder enrolled in the Treatment
of Adolescents with Depression Study. A four-factor solution
resulted, accounting for 65% of the total variance. The
factors were labeled (a) Cognitive Distortions and
Maladaptive Beliefs, (b) Cognitive Avoidance, (c) Positive
Outlook, and (d) Solution-Focused Thinking. Internal
consistencies for the factor-based composite scores were
.83, .85, .84, and .82, respectively. Girls endorsed more
negative cognitions than boys on three of the four factors.
Maladaptive cognitions were positively related to severity
of depression and predicted treatment response. Taken
together, findings indicated that there are four distinct
domains of cognitions that are present among adolescents
with depression that are tapped by several widely used
self-report measures of cognitions.},
Doi = {10.1080/15374410903259015},
Key = {fds271743}
}
@article{fds271744,
Author = {Rogers, GM and Park, J-H and Essex, MJ and Klein, MH and Silva, SG and Hoyle, RH and Curry, JF and Feeny, NC and Kennard, B and Kratochvil, CJ and Pathak, S and Reinecke, MA and Rosenberg, DR and Weller, EB and March,
JS},
Title = {The dysfunctional attitudes scale: psychometric properties
in depressed adolescents.},
Journal = {J Clin Child Adolesc Psychol},
Volume = {38},
Number = {6},
Pages = {781-789},
Year = {2009},
Month = {November},
url = {http://www.ncbi.nlm.nih.gov/pubmed/20183662},
Abstract = {The psychometric properties and factor structure of the
Dysfunctional Attitudes Scale were examined in a sample of
422 male and female adolescents (ages 12-17) with current
major depressive disorder. The scale demonstrated high
internal consistency (alpha = .93) and correlated
significantly with self-report and interview-based measures
of depression. Confirmatory factor analysis indicated that a
correlated 2-factor model, with scales corresponding to
perfectionism and need for social approval, provided a
satisfactory fit to the data. The goodness-of-fit was
equivalent across sexes and age groups. The findings support
the use of the Dysfunctional Attitudes Scale and its
subscales in the assessment of clinically depressed
adolescents.},
Doi = {10.1080/15374410903259007},
Key = {fds271744}
}
@article{fds271727,
Author = {Kratochvil, CJ and May, DE and Silva, SG and Madaan, V and Puumala, SE and Curry, JF and Walkup, J and Kepley, H and Vitiello, B and March,
JS},
Title = {Treatment response in depressed adolescents with and without
co-morbid attention-deficit/hyperactivity disorder in the
Treatment for Adolescents with Depression
Study.},
Journal = {J Child Adolesc Psychopharmacol},
Volume = {19},
Number = {5},
Pages = {519-527},
Year = {2009},
Month = {October},
url = {http://www.ncbi.nlm.nih.gov/pubmed/19877976},
Abstract = {OBJECTIVE: In the Treatment for Adolescents with Depression
Study (TADS), fluoxetine (FLX) and the combination of
fluoxetine with cognitive-behavioral therapy (COMB) had
superior improvement trajectories compared to pill placebo
(PBO), whereas cognitive-behavioral therapy (CBT) was not
significantly different from PBO. Because
attention-deficit/hyperactivity disorder (ADHD) and major
depressive disorder (MDD) frequently co-exist, we examined
whether ADHD moderated these outcomes in TADS. METHOD: A
total of 439 adolescents with MDD, 12-17 years old, were
randomized to FLX, CBT, COMB, or PBO. Random coefficients
regression models examined depression improvement in 377
depressed youths without ADHD and 62 with ADHD, including 20
who were treated with a psychostimulant. RESULTS: Within the
ADHD group, the improvement trajectories of the three active
treatments were similar, all with rates of improvement
greater than PBO. For those without ADHD, only COMB had a
rate of improvement that was superior to PBO. CONCLUSIONS:
Co-morbid ADHD moderated treatment of MDD. CBT alone or FLX
alone may offer benefits similar to COMB in the treatment of
MDD in youths with co-morbid MDD and ADHD, whereas
monotherapy may not match the benefits of COMB for those
without ADHD. The ADHD subgroup analysis presented in this
paper is exploratory in nature because of the small number
of youths with ADHD in the sample. CLINICAL TRIAL REGISTRY:
www.clinicaltrials.gov Identifier: NCT00006286. The TADS
protocol and all of the TADS manuals are available on the
Internet at https://trialweb.dcri.duke.edu/tads/index.html
.},
Doi = {10.1089/cap.2008.0143},
Key = {fds271727}
}
@article{fds271736,
Author = {Treatment for Adolescents With Depression Study (TADS) Team, and March, J and Silva, S and Curry, J and Wells, K and Fairbank, J and Burns, B and Domino, M and Vitiello, B and Severe, J and Riedal, K and Goldman, M and Feeny, N and Findling, R and Stull, S and Baab, S and Weller, EB and Robbins, M and Weller, RA and Jessani, N and Waslick, B and Sweeney, M and Dublin, R and Walkup, J and Ginsburg, G and Kastelic, E and Koo, H and Kratochvil, C and May, D and LaGrone, R and Vaughan, B and Albano, AM and Hirsch, GS and Podniesinki, E and Chu, A and Reincecke,
M and Leventhal, B and Rogers, G and Jacobs, R and Pathak, S and Wells, J and Lavanier, SA and Danielyan, A and Rohde, P and Simons, A and Grimm, J and Frank, S and Emslie, G and Kennard, B and Hughes, C and Mayes, TL and Rosenberg, D and Benazon, N and Butkus, M and Bartoi,
M},
Title = {The Treatment for Adolescents With Depression Study (TADS):
outcomes over 1 year of naturalistic follow-up.},
Journal = {American Journal of Psychiatry},
Volume = {166},
Number = {10},
Pages = {1141-1149},
Year = {2009},
Month = {October},
url = {http://www.ncbi.nlm.nih.gov/pubmed/19723787},
Abstract = {OBJECTIVE: The Treatment for Adolescents With Depression
Study (TADS) evaluates the effectiveness of fluoxetine,
cognitive-behavioral therapy (CBT), and their combination in
adolescents with major depressive disorder. The authors
report effectiveness outcomes across a 1-year naturalistic
follow-up period. METHOD: The randomized, controlled trial
was conducted in 13 academic and community sites in the
United States. Stages I, II, and III consisted of 12, 6, and
18 weeks of acute, consolidation, and continuation
treatment, respectively. Following discontinuation of TADS
treatments at the end of stage III, stage IV consisted of 1
year of naturalistic follow-up. The participants were 327
subjects between the ages of 12 and 17 with a primary DSM-IV
diagnosis of major depressive disorder. No TADS treatment
was provided during the follow-up period; treatment was
available in the community. The primary dependent measures,
rated by an independent evaluator blind to treatment status,
were the total score on the Children's Depression Rating
Scale-Revised and the rate of response, defined as a rating
of much or very much improved on the Clinical Global
Impressions improvement measure. RESULTS: Sixty-six percent
of the eligible subjects participated in at least one stage
IV assessment. The benefits seen at the end of active
treatment (week 36) persisted during follow-up on all
measures of depression and suicidality. CONCLUSIONS: In
contrast to earlier reports on short-term treatments, in
which worsening after treatment is the rule, the longer
treatment in the TADS was associated with persistent
benefits over 1 year of naturalistic follow-up.},
Doi = {10.1176/appi.ajp.2009.08111620},
Key = {fds271736}
}
@article{fds271746,
Author = {Stanley, B and Brown, G and Brent, DA and Wells, K and Poling, K and Curry,
J and Kennard, BD and Wagner, A and Cwik, MF and Klomek, AB and Goldstein,
T and Vitiello, B and Barnett, S and Daniel, S and Hughes,
J},
Title = {Cognitive-behavioral therapy for suicide prevention
(CBT-SP): treatment model, feasibility, and
acceptability.},
Journal = {J Am Acad Child Adolesc Psychiatry},
Volume = {48},
Number = {10},
Pages = {1005-1013},
Year = {2009},
Month = {October},
ISSN = {0890-8567},
url = {http://dx.doi.org/10.1097/CHI.0b013e3181b5dbfe},
Abstract = {OBJECTIVE: To describe the elements of a manual-based
cognitive-behavioral therapy for suicide prevention (CBT-SP)
and to report its feasibility in preventing the recurrence
of suicidal behavior in adolescents who have recently
attempted suicide. METHOD: The CBT-SP was developed using a
risk reduction and relapse prevention approach and
theoretically grounded in principles of cognitive-behavioral
therapy, dialectical behavioral therapy, and targeted
therapies for suicidal youths with depression. The CBT-SP
consists of acute and continuation phases, each lasting
about 12 sessions, and includes a chain analysis of the
suicidal event, safety plan development, skill building,
psychoeducation, family intervention, and relapse
prevention. RESULTS: The CBT-SP was administered to 110
recent suicide attempters with depression aged 13 to 19
years (mean 15.8 years, SD 1.6) across five academic sites.
Twelve or more sessions were completed by 72.4% of the
sample. CONCLUSIONS: A specific intervention for adolescents
at high risk for repeated suicide attempts has been
developed and manual based, and further testing of its
efficacy seems feasible.},
Doi = {10.1097/CHI.0b013e3181b5dbfe},
Key = {fds271746}
}
@article{fds271747,
Author = {Vitiello, B and Brent, DA and Greenhill, LL and Emslie, G and Wells, K and Walkup, JT and Stanley, B and Bukstein, O and Kennard, BD and Compton,
S and Coffey, B and Cwik, MF and Posner, K and Wagner, A and March, JS and Riddle, M and Goldstein, T and Curry, J and Capasso, L and Mayes, T and Shen, S and Gugga, SS and Turner, JB and Barnett, S and Zelazny,
J},
Title = {Depressive symptoms and clinical status during the Treatment
of Adolescent Suicide Attempters (TASA) Study.},
Journal = {J Am Acad Child Adolesc Psychiatry},
Volume = {48},
Number = {10},
Pages = {997-1004},
Year = {2009},
Month = {October},
url = {http://www.ncbi.nlm.nih.gov/pubmed/20854770},
Abstract = {OBJECTIVE: To examine the course of depression during the
treatment of adolescents with depression who had recently
attempted suicide. METHOD: Adolescents (N = 124), ages 12 to
18 years, with a 90-day history of suicide attempt, a
current diagnosis of depressive disorder (96.0% had major
depressive disorder), and a Children's Depression Rating
Scale-Revised (CDRS-R) score of 36 or higher, entered a
6-month treatment with antidepressant medication,
cognitive-behavioral therapy focused on suicide prevention,
or their combination (Comb), at five academic sites.
Treatment assignment could be either random or chosen by
study participants. Intent-to-treat, mixed effects
regression models of depression and other relevant ratings
were estimated. Improvement and remission rates were
computed with the last observation carried forward. RESULTS:
Most patients (n = 104 or 84%) chose treatment assignment,
and overall, three fourths (n = 93) received Comb. In Comb,
CDRS-R declined from a baseline adjusted mean of 49.6 (SD
12.3) to 38.3 (8.0) at week 12 and to 27.0 (10.1) at week 24
(p < .0001), with a Clinical Global Impression -defined
improvement rate of 58.0% at week 12 and 72.2% at week 24
and a remission (CDRS-R ≤ 28) rate of 32.5% at week 12 and
50.0% at week 24. The CDRS-R and the Scale for Suicidal
Ideation scores were correlated at baseline (r = 0.43, p <
.0001) and declined in parallel. CONCLUSIONS: When
vigorously treated with a combination of medication and
psychotherapy, adolescents with depression who have recently
attempted suicide show rates of improvement and remission of
depression that seem comparable to those observed in
nonsuicidal adolescents with depression.},
Doi = {10.1097/CHI.0b013e3181b5db66},
Key = {fds271747}
}
@article{fds271748,
Author = {Brent, DA and Greenhill, LL and Compton, S and Emslie, G and Wells, K and Walkup, JT and Vitiello, B and Bukstein, O and Stanley, B and Posner, K and Kennard, BD and Cwik, MF and Wagner, A and Coffey, B and March, JS and Riddle, M and Goldstein, T and Curry, J and Barnett, S and Capasso, L and Zelazny, J and Hughes, J and Shen, S and Gugga, SS and Turner,
JB},
Title = {The Treatment of Adolescent Suicide Attempters study (TASA):
predictors of suicidal events in an open treatment
trial.},
Journal = {J Am Acad Child Adolesc Psychiatry},
Volume = {48},
Number = {10},
Pages = {987-996},
Year = {2009},
Month = {October},
url = {http://www.ncbi.nlm.nih.gov/pubmed/19730274},
Abstract = {OBJECTIVE: To identify the predictors of suicidal events and
attempts in adolescent suicide attempters with depression
treated in an open treatment trial. METHOD: Adolescents who
had made a recent suicide attempt and had unipolar
depression (n =124) were either randomized (n = 22) or given
a choice (n = 102) among three conditions. Two participants
withdrew before treatment assignment. The remaining 124
youths received a specialized psychotherapy for suicide
attempting adolescents (n = 17), a medication algorithm (n =
14), or the combination (n = 93). The participants were
followed up 6 months after intake with respect to rate,
timing, and predictors of a suicidal event (attempt or acute
suicidal ideation necessitating emergency referral).
RESULTS: The morbid risks of suicidal events and attempts on
6-month follow-up were 0.19 and 0.12, respectively, with a
median time to event of 44 days. Higher self-rated
depression, suicidal ideation, family income, greater number
of previous suicide attempts, lower maximum lethality of
previous attempt, history of sexual abuse, and lower family
cohesion predicted the occurrence, and earlier time to
event, with similar findings for the outcome of attempts. A
slower decline in suicidal ideation was associated with the
occurrence of a suicidal event. CONCLUSIONS: In this open
trial, the 6-month morbid risks for suicidal events and for
reattempts were lower than those in other comparable
samples, suggesting that this intervention should be studied
further. Important treatment targets include suicidal
ideation, family cohesion, and sequelae of previous abuse.
Because 40% of events occurred with 4 weeks of intake, an
emphasis on safety planning and increased therapeutic
contact early in treatment may be warranted.},
Doi = {10.1097/CHI.0b013e3181b5dbe4},
Key = {fds271748}
}
@article{fds271749,
Author = {Curry, JF},
Title = {Research psychotherapy: Aspirin or music?},
Journal = {Clinical Psychology: Science and Practice},
Volume = {16},
Number = {3},
Pages = {318-322},
Publisher = {WILEY},
Year = {2009},
Month = {September},
ISSN = {0969-5893},
url = {http://dx.doi.org/10.1111/j.1468-2850.2009.01169.x},
Abstract = {Beutler's call for an expanded psychotherapy agenda is
appropriate but does not require downgrading the role of
randomized clinical trials (RCTs). Large-scale RCTs are
necessary to address questions of general public health
importance. Within RCTs, psychotherapy can be conducted in a
flexible, creative manner, similar to the practice of good
clinicians. The aspirin analogy drawn from Klerman is not
illustrative of how psychotherapy is actually conducted in
contemporary clinical trials. A better analogy is that of
music, which not only involves known ingredients and
trainable, replicable skills, but also permits tailoring and
improvisation. By conducting large RCTs, secondary analyses
of these studies, and smaller controlled trials,
psychotherapy researchers can address many clinically
relevant questions. © 2009 Society of Clinical
Psychology.},
Doi = {10.1111/j.1468-2850.2009.01169.x},
Key = {fds271749}
}
@article{fds271750,
Author = {Becker, SJ and Curry, JF and Yang, C},
Title = {Longitudinal association between frequency of substance use
and quality of life among adolescents receiving a brief
outpatient intervention.},
Journal = {Psychology of Addictive Behaviors : Journal of the Society
of Psychologists in Addictive Behaviors},
Volume = {23},
Number = {3},
Pages = {482-490},
Year = {2009},
Month = {September},
ISSN = {0893-164X},
url = {http://www.ncbi.nlm.nih.gov/pubmed/19769432},
Abstract = {Recognition of the broad consequences of adolescent
substance abuse has led to increased emphasis on balancing
traditional measures of treatment effectiveness, such as
frequency of substance use, with measures of patient
functioning and quality of life (QOL). This study evaluated
the longitudinal association between frequency of use and
QOL among adolescent substance abusers receiving a brief
outpatient intervention. Participants were 106 adolescents,
aged 13 to 21 years, who met criteria for substance abuse or
dependence and completed 4 assessments over a 12 month
period. Results of a parallel-process latent growth curve
model indicated a moderate longitudinal association, such
that reduced frequency of use was associated with QOL
improvement. Elaboration of the temporal ordering of this
association via a cross-lagged panel model revealed that
frequency of substance use predicted subsequent QOL, but
that QOL did not predict subsequent frequency of use.
Implications pertaining to the assessment of comprehensive
outcomes and the setting of treatment expectations are
discussed.},
Doi = {10.1037/a0016579},
Key = {fds271750}
}
@article{fds271726,
Author = {Rush, CC and Becker, SJ and Curry, JF},
Title = {Personality factors and styles among college students who
binge eat and drink.},
Journal = {Psychology of Addictive Behaviors : Journal of the Society
of Psychologists in Addictive Behaviors},
Volume = {23},
Number = {1},
Pages = {140-145},
Year = {2009},
Month = {March},
ISSN = {0893-164X},
url = {http://www.ncbi.nlm.nih.gov/pubmed/19290698},
Abstract = {Elevated rates of comorbidity between binge eating and
alcohol use problems have been widely documented. Prior
studies have examined specific personality traits associated
with the co-occurrence of these problems. The current study
explores comprehensive personality factors that are
associated with the co-occurrence of binge eating and binge
drinking among a diverse sample of 208 college
undergraduates. Using the Five Factor Model of personality,
the authors assessed both comprehensive personality factors
and style of impulse control, a personality style defined by
different combinations of neuroticism and conscientiousness.
On the basis of responses to a screening instrument, college
students were assigned to one of four groups: binge eat,
binge drink, binge eat and drink, and non-binge. The binge
eat and drink group reported a higher level of neuroticism
than did students in the binge drink and non-binge groups.
Additionally, the binge eat and drink group was more likely
to report an undercontrolled style of impulse control than
were other groups. (PsycINFO Database Record (c) 2009 APA,
all rights reserved).},
Doi = {10.1037/a0013167},
Key = {fds271726}
}
@article{fds271751,
Author = {Kennard, BD and Silva, SG and Mayes, TL and Rohde, P and Hughes, JL and Vitiello, B and Kratochvil, CJ and Curry, JF and Emslie, GJ and Reinecke, MA and March, JS and TADS},
Title = {Assessment of safety and long-term outcomes of initial
treatment with placebo in TADS.},
Journal = {American Journal of Psychiatry},
Volume = {166},
Number = {3},
Pages = {337-344},
Year = {2009},
Month = {March},
url = {http://www.ncbi.nlm.nih.gov/pubmed/19147693},
Abstract = {OBJECTIVE: The authors examined whether initial assignment
to receive placebo for 12 weeks followed by open active
treatment as clinically indicated was associated with
different levels of benefit and risk of harm across 36 weeks
as compared with initial assignment to receive active
treatments. METHOD: Adolescents with major depressive
disorder (N=439) were randomly assigned to receive an
initial 12 weeks of treatment with fluoxetine,
cognitive-behavioral therapy (CBT), combination treatment
with fluoxetine and CBT, or clinical management with
placebo; those assigned to placebo received open active
treatment as clinically indicated after 12 weeks of placebo.
Assessments were conducted every 6 weeks for 36 weeks. The
primary outcome measures were response and remission based
on scores on the Children's Depression Rating Scale-Revised
and the Clinical Global Impression improvement subscale.
RESULTS: At week 36, the response rate was 82% in the
placebo/open group and 83% in the active treatment groups.
The remission rate was 48% in the placebo/open group and 59%
in the active treatment groups, a difference that approached
statistical significance. Patients who responded to placebo
generally retained their response. Those who did not respond
to placebo subsequently responded to active treatment at the
same rate as those initially assigned to active treatments.
There were no differences between groups in rates of
suicidal events, study retention, or symptom worsening.
CONCLUSIONS: Remission rates at 9 months were lower in
patients treated initially with placebo, but 3 months of
placebo treatment was not associated with any harm or
diminished response to subsequent treatment.},
Doi = {10.1176/appi.ajp.2008.08040487},
Key = {fds271751}
}
@article{fds271752,
Author = {Kennard, BD and Silva, SG and Tonev, S and Rohde, P and Hughes, JL and Vitiello, B and Kratochvil, CJ and Curry, JF and Emslie, GJ and Reinecke, M and March, J},
Title = {Remission and recovery in the Treatment for Adolescents with
Depression Study (TADS): acute and long-term
outcomes.},
Journal = {J Am Acad Child Adolesc Psychiatry},
Volume = {48},
Number = {2},
Pages = {186-195},
Year = {2009},
Month = {February},
ISSN = {0890-8567},
url = {http://dx.doi.org/10.1097/CHI.0b013e31819176f9},
Abstract = {OBJECTIVE: We examine remission rate probabilities, recovery
rates, and residual symptoms across 36 weeks in the
Treatment for Adolescents with Depression Study (TADS).
METHOD: The TADS, a multisite clinical trial, randomized 439
adolescents with major depressive disorder to 12 weeks of
treatment with fluoxetine, cognitive-behavioral therapy,
their combination, or pill placebo. The pill placebo group,
treated openly after week 12, was not included in the
subsequent analyses. Treatment differences in remission
rates and probabilities of remission over time are compared.
Recovery rates in remitters at weeks 12 (acute phase
remitters) and 18 (continuation phase remitters) are
summarized. We also examined whether residual symptoms at
the end of 12 weeks of acute treatment predicted later
remission. RESULTS: At week 36, the estimated remission
rates for intention-to-treat cases were as follows:
combination, 60%; fluoxetine, 55%; cognitive-behavioral
therapy, 64%; and overall, 60%. Paired comparisons reveal
that, at week 24, all active treatments converge on
remission outcomes. The recovery rate at week 36 was 65% for
acute phase remitters and 71% for continuation phase
remitters, with no significant between-treatment differences
in recovery rates. Residual symptoms at the end of acute
treatment predicted failure to achieve remission at weeks 18
and 36. CONCLUSIONS: Most depressed adolescents in all three
treatment modalities achieved remission at the end of 9
months of treatment.},
Doi = {10.1097/CHI.0b013e31819176f9},
Key = {fds271752}
}
@article{fds271745,
Author = {Reinecke, MA and Curry, JF and March, JS},
Title = {Findings from the Treatment for Adolescents with Depression
Study (TADS)},
Journal = {Journal of Clinical Child and Adolescent
Psychology},
Volume = {38},
Pages = {761-767},
Year = {2009},
Key = {fds271745}
}
@article{fds271724,
Author = {Becker, SJ and Sanchez, CC and Curry, JF and Silva, S and Tonev,
S},
Title = {Cognitive-behavioral therapy for adolescent
depression},
Journal = {Psychiatric Times},
Volume = {25},
Number = {14},
Pages = {46-48},
Year = {2008},
Month = {December},
ISSN = {0893-2905},
Abstract = {Cognitive variables that predict favorable treatment
outcomes in adolescents with depression include higher
levels of rational thoughts, less hopelessness, fewer
negative thoughts, and fewer cognitive distortions at
baseline. 10,14,22 In an analysis of TADS data, cognitive
distortions at baseline were also shown to moderate the
effects of combined CBT and fluoxetine, such that
adolescents with high levels of cognitive distortion were
more likely to experience incremental benefits from CBT as
part of combination treatment. 31 In an analysis of the
Brent study, hopelessness was found to mediate the
predictive effects of referral source on outcome across 3
types of psychotherapy. 14 The only variables that have been
found to mediate the results of CBT specifically are
negative automatic thoughts, and in a small subclinical
sample, dysfunctional attitudes, which suggests that a
reduction in these variables may be important mechanisms of
change in CBT. 17,23 Mediational analyses have not yet been
conducted on the TADS data, which precludes conclusions
about the mechanisms of change in pharmacological and
combination treatments. Further research is needed to
uncover the specific strategies used in therapy that reframe
negative cognition, modify dysfunctional beliefs, and
improve depressive symptoms.},
Key = {fds271724}
}
@article{fds271754,
Author = {Becker, SJ and Curry, JF},
Title = {Outpatient interventions for adolescent substance abuse: a
quality of evidence review.},
Journal = {J Consult Clin Psychol},
Volume = {76},
Number = {4},
Pages = {531-543},
Year = {2008},
Month = {August},
url = {http://www.ncbi.nlm.nih.gov/pubmed/18665683},
Abstract = {Previous reviews of outpatient interventions for adolescent
substance abuse have been limited in the extent to which
they considered the methodological quality of individual
studies. The authors assessed 31 randomized trials of
outpatient interventions for adolescent substance abuse on
14 attributes of trial quality. A quality of evidence score
was calculated for each study and used to compare the
evidence in support of different outpatient interventions.
Across studies, frequently reported methodological
attributes included presence of an active comparison
condition, reporting of baseline data, use of treatment
manuals, and verification of self-reported outcomes.
Infrequently reported attributes included power and
determination of sample size, techniques to randomize
participants to condition, specification of hypotheses and
primary outcomes, use of treatment adherence ratings, blind
assessment, and inclusion of dropouts in the analysis.
Treatment models with evidence of immediate superiority in 2
or more methodologically stronger studies included
ecological family therapy, brief motivational interventions,
and cognitive-behavioral therapy.},
Doi = {10.1037/0022-006X.76.4.531},
Key = {fds271754}
}
@article{fds271723,
Author = {Rohde, P and Silva, SG and Tonev, ST and Kennard, BD and Vitiello, B and Kratochvil, CJ and Reinecke, MA and Curry, JF and Simons, AD and March,
JS},
Title = {Achievement and maintenance of sustained response during the
Treatment for Adolescents With Depression Study continuation
and maintenance therapy.},
Journal = {Arch Gen Psychiatry},
Volume = {65},
Number = {4},
Pages = {447-455},
Year = {2008},
Month = {April},
url = {http://www.ncbi.nlm.nih.gov/pubmed/18391133},
Abstract = {CONTEXT: The Treatment for Adolescents With Depression Study
evaluated fluoxetine (FLX), cognitive behavioral therapy
(CBT), and FLX/CBT combination (COMB) vs pill placebo in 439
adolescents with major depressive disorder. Treatment
consisted of 3 stages: (1) acute (12 weeks), (2)
continuation (6 weeks), and (3) maintenance (18 weeks).
OBJECTIVE: To examine rates of achieving and maintaining
sustained response during continuation and maintenance
treatments. DESIGN: Randomized controlled trial. Response
was determined by blinded independent evaluators. SETTING:
Thirteen US sites. PATIENTS: Two hundred forty-two FLX, CBT,
and COMB patients in their assigned treatment at the end of
stage 1. INTERVENTIONS: Stage 2 treatment varied based on
stage 1 response. Stage 3 consisted of 3 CBT and/or
pharmacotherapy sessions and, if applicable, continued
medication. MAIN OUTCOME MEASURES: Sustained response was
defined as 2 consecutive Clinical Global
Impression-Improvement ratings of 1 or 2 ("full response").
Patients achieving sustained response were classified on
subsequent nonresponse status. RESULTS: Among 95 patients
(39.3%) who had not achieved sustained response by week 12
(29.1% COMB, 32.5% FLX, and 57.9% CBT), sustained response
rates during stages 2 and 3 were 80.0% COMB, 61.5% FLX, and
77.3% CBT (difference not significant). Among the remaining
147 patients (60.7%) who achieved sustained response by week
12, CBT patients were more likely than FLX patients to
maintain sustained response through week 36 (96.9% vs 74.1%;
P = .007; 88.5% of COMB patients maintained sustained
response through week 36). Total rates of sustained response
by week 36 were 88.4% COMB, 82.5% FLX, and 75.0% CBT.
CONCLUSIONS: Most adolescents with depression who had not
achieved sustained response during acute treatment did
achieve that level of improvement during continuation and
maintenance therapies. The possibility that CBT may help the
subset of adolescents with depression who achieve early
sustained response maintain their response warrants further
investigation. TRIAL REGISTRATION: clinicaltrials.gov
Identifier: NCT00006286.},
Doi = {10.1001/archpsyc.65.4.447},
Key = {fds271723}
}
@article{fds271753,
Author = {Kaminer, Y and Connor, DF and Curry, JF},
Title = {Treatment of comorbid adolescent cannabis use and major
depressive disorder},
Journal = {Psychiatry},
Volume = {5},
Pages = {43-48},
Year = {2008},
Key = {fds271753}
}
@article{fds271755,
Author = {Rohde, P and Silva, S and Tonev, ST and Kennard, BD and Vitiello, B and Kratochvil, CJ and Reinecke, MA and Curry, JF and Simons, AD and March,
JS},
Title = {Achievement and maintenance of sustained response during
TADS continuation and maintenance therapy},
Journal = {Archives of General Psychaitry},
Volume = {65},
Pages = {447-455},
Year = {2008},
Key = {fds271755}
}
@article{fds271757,
Author = {Vitiello, B and Kratochvil, CJ and Silva, S and Curry, J and Reinecke,
M and Pathak, S and Waslick, B and Hughes, CW and Prentice, ED and May, DE and March, JS},
Title = {Research knowledge among the participants in the Treatment
for Adolescents With Depression Study (TADS).},
Journal = {Journal of the American Academy of Child and Adolescent
Psychiatry},
Volume = {46},
Number = {12},
Pages = {1642-1650},
Year = {2007},
Month = {December},
ISSN = {0890-8567},
url = {http://www.ncbi.nlm.nih.gov/pubmed/18030086},
Abstract = {OBJECTIVE: We examined the extent to which parents and
adolescents participating in the Treatment for Adolescents
With Depression Study (TADS) understood key aspects of the
study. METHOD: TADS was a clinical trial comparing the
effectiveness of fluoxetine, cognitive-behavioral therapy
(CBT), their combination, and placebo in 439 adolescents
(12-17 years old) with major depressive disorder. Six weeks
after starting treatment, adolescents and their parents were
asked to complete a questionnaire about critical elements of
the trial. RESULTS: Completion rate was 67.2% for
adolescents (N = 295) and 73.6% for parents (N = 323). More
than 90% of the completers knew of the main purpose of the
trial, possible assignment to placebo, and their right to
withdraw participation at any time. However, about one third
overall (and 49% in the CBT group) described TADS as
"education" rather than "research." Of 12 questions, the
mean number of correct answers was 10.3 (SD 1.7) among
adolescents and 11.2 (SD 1.2) among parents (p <.0001). The
most frequently stated reason for TADS participation was the
pursuit of high-quality care. CONCLUSIONS: Most parents and
adolescents were well-informed research participants.
Difficulties in appreciating the research nature of the
trial, however, emerged, especially among participants
assigned to psychotherapy. Parents were overall better
informed than adolescents.},
Doi = {10.1097/chi.0b013e318153f8c7},
Key = {fds271757}
}
@article{fds271758,
Author = {March, JS and Silva, S and Petrycki, S and Curry, J and Wells, K and Fairbank, J and Burns, B and Domino, M and McNulty, S and Vitiello, B and Severe, J},
Title = {The Treatment for Adolescents With Depression Study (TADS):
long-term effectiveness and safety outcomes.},
Journal = {Archives of General Psychiatry},
Volume = {64},
Number = {10},
Pages = {1132-1143},
Year = {2007},
Month = {October},
ISSN = {0003-990X},
url = {http://www.ncbi.nlm.nih.gov/pubmed/17909125},
Abstract = {CONTEXT: The Treatment for Adolescents With Depression Study
evaluates the effectiveness of fluoxetine hydrochloride
therapy, cognitive behavior therapy (CBT), and their
combination in adolescents with major depressive disorder.
OBJECTIVE: To report effectiveness outcomes across 36 weeks
of randomized treatment. DESIGN AND SETTING: Randomized,
controlled trial conducted in 13 academic and community
sites in the United States. Cognitive behavior and
combination therapies were not masked, whereas
administration of placebo and fluoxetine was double-blind
through 12 weeks, after which treatments were unblinded.
Patients assigned to placebo were treated openly after week
12, and the placebo group is not included in these analyses
by design. PARTICIPANTS: Three hundred twenty-seven patients
aged 12 to 17 years with a primary DSM-IV diagnosis of major
depressive disorder. INTERVENTIONS: All treatments were
administered per protocol. MAIN OUTCOME MEASURES: The
primary dependent measures rated blind to treatment status
by an independent evaluator were the Children's Depression
Rating Scale-Revised total score and the response rate,
defined as a Clinical Global Impressions-Improvement score
of much or very much improved. RESULTS: Intention-to-treat
analyses on the Children's Depression Rating Scale-Revised
identified a significant time x treatment interaction (P <
.001). Rates of response were 73% for combination therapy,
62% for fluoxetine therapy, and 48% for CBT at week 12; 85%
for combination therapy, 69% for fluoxetine therapy, and 65%
for CBT at week 18; and 86% for combination therapy, 81% for
fluoxetine therapy, and 81% for CBT at week 36. Suicidal
ideation decreased with treatment, but less so with
fluoxetine therapy than with combination therapy or CBT.
Suicidal events were more common in patients receiving
fluoxetine therapy (14.7%) than combination therapy (8.4%)
or CBT (6.3%). CONCLUSIONS: In adolescents with moderate to
severe depression, treatment with fluoxetine alone or in
combination with CBT accelerates the response. Adding CBT to
medication enhances the safety of medication. Taking
benefits and harms into account, combined treatment appears
superior to either monotherapy as a treatment for major
depression in adolescents.},
Doi = {10.1001/archpsyc.64.10.1132},
Key = {fds271758}
}
@article{fds271763,
Author = {Hughes, CW and Emslie, GJ and Crismon, ML and Posner, K and Birmaher, B and Ryan, N and Jensen, P and Curry, J and Vitiello, B and Lopez, M and Shon,
SP and Pliszka, SR and Trivedi, MH and TEXAS CONSENSUS CONFERENCE
PANEL ON MEDICATION TREATMENT OF CHILDHOOD MAJOR DEPRESSIVE
DISORDER},
Title = {Texas Children's Medication Algorithm Project: update from
Texas Consensus Conference Panel on Medication Treatment of
Childhood Major Depressive Disorder.},
Journal = {Journal of the American Academy of Child and Adolescent
Psychiatry},
Volume = {46},
Number = {6},
Pages = {667-686},
Year = {2007},
Month = {June},
ISSN = {0890-8567},
url = {http://dx.doi.org/10.1097/chi.0b013e31804a859b},
Abstract = {OBJECTIVE: To revise and update consensus guidelines for
medication treatment algorithms for childhood major
depressive disorder based on new scientific evidence and
expert clinical consensus when evidence is lacking. METHOD:
A consensus conference was held January 13-14, 2005, that
included academic clinicians and researchers, practicing
clinicians, administrators, consumers, and families. The
focus was to review, update, and incorporate the most
current data to inform and recommend specific
pharmacological approaches and clinical guidance for
treatment of major depressive disorder in children and
adolescents. RESULTS: Consensually agreed on medication
algorithms for major depression (with and without psychosis)
and comorbid attention-deficit disorders were updated. These
revised algorithms also incorporated approaches to address
issues of suicidality, aggression, and irritability. Stages
1, 2, and 3 of the algorithm consist of selective serotonin
reuptake inhibitor and norepinephrine serotonin reuptake
inhibitor medications whose use is supported by controlled,
acute clinical trials and clinical experience. Recent
studies provide support that selective serotonin reuptake
inhibitors in addition to fluoxetine are still encouraged as
first-line interventions. The need for additional
assessments, precautions, and monitoring is emphasized, as
well as continuation and maintenance treatment. CONCLUSIONS:
Evidence and expert clinical consensus support the use of
selected antidepressants in the treatment of depression in
youths. The use of the recommended antidepressant
medications requires appropriate monitoring of suicidality
and potential adverse effects and consideration of other
evidence-based treatment alternatives such as cognitive
behavioral therapies.},
Doi = {10.1097/chi.0b013e31804a859b},
Key = {fds271763}
}
@article{fds271756,
Author = {Kaminer, Y and Connor, DF and Curry, JF},
Title = {Comorbid adolescent substance use and major depressive
disorders: A review},
Journal = {Psychiatry},
Volume = {4},
Pages = {32-43},
Year = {2007},
Key = {fds271756}
}
@article{fds271760,
Author = {Becker, SJ and Curry, JF},
Title = {Interactive effect of substance abuse and depression on
adolescent social competence.},
Journal = {Journal of Clinical Child and Adolescent Psychology : the
Official Journal for the Society of Clinical Child and
Adolescent Psychology, American Psychological Association,
Division 53},
Volume = {36},
Number = {3},
Pages = {469-475},
Year = {2007},
ISSN = {1537-4416},
url = {http://www.ncbi.nlm.nih.gov/pubmed/17658989},
Abstract = {This study explored the interactive effect of substance
abuse and depression on social competence among 106
adolescent inpatients (57% female, 86% Caucasian). Substance
abuse and depression were conceptualized using dimensional
ratings of illness severity based on adolescent interviews,
whereas social competence was conceptualized using parent
ratings of adolescent behavior. Cross-sectional analyses
revealed that substance abuse and depression had a negative
interactive effect on adolescent social competence: Higher
severity levels of both dimensions were associated with
lower levels of competence than accounted for by the
additive effects of the two dimensions. These findings
persisted when controlling for gender, race, and other
common dimensions of psychopathology. Significant impairment
in social competence occurred at subdiagnostic levels of
substance abuse when depression severity was high,
highlighting the value of assessing outcomes across the full
range of severity.},
Doi = {10.1080/15374410701448638},
Key = {fds271760}
}
@article{fds271761,
Author = {Kratochvil, C and Emslie, G and Silva, S and McNulty, S and Walkup, J and Curry, J and Reinecke, M and Vitiello, B and Rohde, P and Feeny, N and Casat, C and Pathak, S and Weller, E and May, D and Mayes, T and Robins, M and March, J and TADS Team},
Title = {Acute time to response in the Treatment for Adolescents with
Depression Study (TADS).},
Journal = {Journal of the American Academy of Child and Adolescent
Psychiatry},
Volume = {45},
Number = {12},
Pages = {1412-1418},
Year = {2006},
Month = {December},
ISSN = {0890-8567},
url = {http://dx.doi.org/10.1097/01.chi.0000237710.73755.14},
Abstract = {OBJECTIVE: To examine the time to response for both
pharmacotherapy and psychotherapy in the Treatment for
Adolescents with Depression Study (TADS). METHOD:
Adolescents (N = 439, ages 12 to 17 years) with major
depressive disorder were randomized to fluoxetine (FLX),
cognitive-behavioral therapy (CBT), their combination
(COMB), or pill placebo (PBO). Defining response as very
much improved or much improved on the Clinical Global
Impression-Improvement Scale (CGI-I), survival analyses
using Cox proportional hazards models, and Kaplan-Meier
curves were conducted to evaluate time to first response and
time to stable response for subjects receiving
pharmacotherapy (COMB, FLX, PBO) as well as for subjects
receiving CBT (COMB, CBT). Direct comparisons between
pharmacotherapy and CBT were not made because of differences
in visit schedules. RESULTS: Based on pharmacotherapist
CGI-I scores, COMB and FLX showed faster onset of benefit
than PBO on time to response and time to stable response (p
< .001), and COMB was faster than FLX on time to stable
response (p = .034). The probability of sustained early
response was approximately threefold greater for COMB than
PBO, twofold greater for FLX than PBO, and 1.5-fold greater
for COMB than FLX. On the psychotherapist CGI-I scores, both
first response and stable response occurred faster in COMB
than CBT (p < .001), with a probability of sustained early
response approximately threefold greater for COMB than CBT.
CONCLUSIONS: In the acute treatment of depressed
adolescents, FLX and COMB accelerate response relative to
PBO, and COMB accelerates response relative to CBT
alone.},
Doi = {10.1097/01.chi.0000237710.73755.14},
Key = {fds271761}
}
@article{fds271762,
Author = {Kennard, B and Silva, S and Vitiello, B and Curry, J and Kratochvil, C and Simons, A and Hughes, J and Feeny, N and Weller, E and Sweeney, M and Reinecke, M and Pathak, S and Ginsburg, G and Emslie, G and March, J and TADS Team},
Title = {Remission and residual symptoms after short-term treatment
in the Treatment of Adolescents with Depression Study
(TADS).},
Journal = {Journal of the American Academy of Child and Adolescent
Psychiatry},
Volume = {45},
Number = {12},
Pages = {1404-1411},
Year = {2006},
Month = {December},
ISSN = {0890-8567},
url = {http://dx.doi.org/10.1097/01.chi.0000242228.75516.21},
Abstract = {OBJECTIVE: To ascertain remission rates in depressed youth
participating in the Treatment for Adolescents With
Depression Study (TADS), a multisite clinical trial that
randomized 439 adolescents with major depressive disorder
(MDD) to a 12-week treatment of fluoxetine (FLX),
cognitive-behavioral therapy (CBT), their combination
(COMB), or clinical management with pill placebo (PBO).
METHOD: Using an end-of-treatment Children's Depression
Rating Scale-Revised (CDRS-R) total score of 28 or below as
the criterion for remission, rates of remission were
examined with logistic regression, controlling for site.
Loss of MDD diagnosis and residual symptoms in responders
(defined as Clinical Global Impressions-Improvement (CGI-I)
score of 1 (very much improved) or 2 (much improved) were
also examined across treatment groups. RESULTS: After 12
weeks of treatment, 102 (23%) of 439 youths had reached
remission. The remission rate was significantly higher in
the COMB group (37%) relative to the other treatment groups
(FLX, 23%; CBT, 16%; PBO, 17%), with odds ratios of 2.1 for
COMB versus FLX, 3.3 for COMB versus CBT, and 3.0 for COMB
versus PBO. In addition, 71% of subjects across treatment
groups no longer met criteria for MDD at the end of acute
treatment. Fifty percent of the youths who responded by
CGI-I criteria continued to have residual symptoms, such as
sleep or mood disturbances, fatigue, and poor concentration.
CONCLUSIONS: The combination of FLX and CBT was superior to
both monotherapy and PBO in terms of remission rates, but
overall rates of remission remain low and residual symptoms
are common at the end of 12 weeks of treatment.},
Doi = {10.1097/01.chi.0000242228.75516.21},
Key = {fds271762}
}
@article{fds271764,
Author = {Curry, J and Rohde, P and Simons, A and Silva, S and Vitiello, B and Kratochvil, C and Reinecke, M and Feeny, N and Wells, K and Pathak, S and Weller, E and Rosenberg, D and Kennard, B and Robins, M and Ginsburg, G and March, J and TADS Team},
Title = {Predictors and moderators of acute outcome in the Treatment
for Adolescents with Depression Study (TADS).},
Journal = {Journal of the American Academy of Child and Adolescent
Psychiatry},
Volume = {45},
Number = {12},
Pages = {1427-1439},
Year = {2006},
Month = {December},
ISSN = {0890-8567},
url = {http://dx.doi.org/10.1097/01.chi.0000240838.78984.e2},
Abstract = {OBJECTIVE: To identify predictors and moderators of response
to acute treatments among depressed adolescents (N = 439)
randomly assigned to fluoxetine, cognitive-behavioral
therapy (CBT), both fluoxetine and CBT, or clinical
management with pill placebo in the Treatment for
Adolescents With Depression Study (TADS). METHOD: Potential
baseline predictors and moderators were identified by a
literature review. The outcome measure was a week 12
predicted score derived from the Children's Depression
Rating Scale-Revised (CDRS-R). For each candidate moderator
or predictor, a general linear model was conducted to
examine main and interactive effects of treatment and the
candidate variable on the CDRS-R predicted scores. RESULTS:
Adolescents who were younger, less chronically depressed,
higher functioning, and less hopeless with less suicidal
ideation, fewer melancholic features or comorbid diagnoses,
and greater expectations for improvement were more likely to
benefit acutely than their counterparts. Combined treatment,
under no condition less effective than monotherapy, was more
effective than fluoxetine for mild to moderate depression
and for depression with high levels of cognitive distortion,
but not for severe depression or depression with low levels
of cognitive distortion. Adolescents from high-income
families were as likely to benefit from CBT alone as from
combined treatment. CONCLUSIONS: Younger and less severely
impaired adolescents are likely to respond better to acute
treatment than older, more impaired, or multiply comorbid
adolescents. Family income level, cognitive distortions, and
severity of depression may help clinicians to choose among
acute interventions, but combined treatment proved robust in
the presence of moderators.},
Doi = {10.1097/01.chi.0000240838.78984.e2},
Key = {fds271764}
}
@article{fds271735,
Author = {Chrisman, A and Egger, H and Compton, SN and Curry, J and Goldston,
DB},
Title = {Assessment of Childhood Depression.},
Journal = {Child and Adolescent Mental Health},
Volume = {11},
Number = {2},
Pages = {111-116},
Publisher = {WILEY},
Year = {2006},
Month = {May},
ISSN = {1475-357X},
url = {http://dx.doi.org/10.1111/j.1475-3588.2006.00395.x},
Abstract = {Depression as a disorder in childhood began to be
increasingly recognised in the 1970s. Epidemiologic
community and clinic-based studies have characterised the
prevalence, clinical course, and complications of this
illness throughout childhood and adolescence into adulthood.
This paper reviews two instruments for assessing depression
in prepubertal children - the Dominic Interactive and The
Preschool Age Psychiatric Assessment. Both instruments are
useful in screening for psychiatric disorders and reliably
identifying the presence of depressive symptoms in young
children.},
Doi = {10.1111/j.1475-3588.2006.00395.x},
Key = {fds271735}
}
@article{fds271767,
Author = {Hervey, AS and Epstein, JN and Curry, JF and Tonev, S and Eugene Arnold,
L and Keith Conners and C and Hinshaw, SP and Swanson, JM and Hechtman,
L},
Title = {Reaction time distribution analysis of neuropsychological
performance in an ADHD sample.},
Journal = {Child Neuropsychology : a Journal on Normal and Abnormal
Development in Childhood and Adolescence},
Volume = {12},
Number = {2},
Pages = {125-140},
Year = {2006},
Month = {April},
ISSN = {0929-7049},
url = {http://dx.doi.org/10.1080/09297040500499081},
Abstract = {Differences in reaction time (RT) variability have been
documented between children with and without Attention
Deficit Hyperactivity Disorder (ADHD). Most previous
research has utilized estimates of normal distributions to
examine variability. Using a nontraditional approach, the
present study evaluated RT distributions on the Conners'
Continuous Performance Test in children and adolescents from
the Multimodal Treatment Study of ADHD sample compared to a
matched sample of normal controls (n = 65 pairs). The
ex-Gaussian curve was used to model RT and RT variability.
Children with ADHD demonstrated faster RT associated with
the normal portion of the curve and a greater proportion of
abnormally slow responses associated with the exponential
portion of the curve. These results contradict previous
interpretation that children with ADHD have slower than
normal responding and demonstrate why slower RT is found
when estimates of variability assume normal Gaussian
distributions. Further, results of this study suggest that
the greater number of abnormally long RTs of children with
ADHD reflect attentional lapses on some but not all
trials.},
Doi = {10.1080/09297040500499081},
Key = {fds271767}
}
@article{fds271734,
Author = {Chabrol, H},
Title = {CBT versus supportive therapy for depression.},
Journal = {Journal of the American Academy of Child and Adolescent
Psychiatry},
Volume = {44},
Number = {9},
Pages = {841},
Year = {2005},
Month = {September},
url = {http://dx.doi.org/10.1097/01.chi.0000170555.00551.37},
Doi = {10.1097/01.chi.0000170555.00551.37},
Key = {fds271734}
}
@article{fds271722,
Author = {Curry, JF and Wells, KC},
Title = {Striving for effectiveness in the treatment of adolescent
depression: Cognitive behavior therapy for multisite
community intervention},
Journal = {Cognitive and Behavioral Practice},
Volume = {12},
Number = {2},
Pages = {177-185},
Publisher = {Elsevier BV},
Year = {2005},
Month = {January},
url = {http://dx.doi.org/10.1016/S1077-7229(05)80023-9},
Abstract = {The Treatment for Adolescents With Depression Study (TADS)
was designed to compare the relative and combined
effectiveness of cognitive, behavior therapy (CBT) and
fluoxetine, each of which had demonstrated efficacy in
carefully controlled single-site studies. Models of CBT from
these efficacy studies served as the foundation for the TADS
psychosocial intervention. When interpreting the acute and
long-term outcomes of TADS treatment in the context of other
studies of CBT for major depression, it is critical to
understand the process and the decision making that formed
the TADS CBT intervention. The TADS CBT Committee reviewed
meta-analyses of child and adolescent psychotherapy as well
as studies of CBT for childhood and, adolescent depression,
relied on expert consultants, and evaluated the treatment
process in a feasibility study to derive the essential
components of TADS CBT. In this article we describe the
rationale for the TADS CBT, the process of treatment design,
and the. immediate sources of the TADS treatment. Key
decisions were made involving the degree of treatment
structure, therapist flexibility versus cross-site
consistency, duration and intensity of treatment, the
involvement of family members in treatment, and core versus
optional elements of the intevention. Copyright © 2005 by
Association for Advancement of Behavior Therapy. All rights
of reproduction in any form reserved.},
Doi = {10.1016/S1077-7229(05)80023-9},
Key = {fds271722}
}
@article{fds271765,
Author = {Rogers, GM and Reinecke, MA and Curry, JF},
Title = {Case formulation in TADS CBT},
Journal = {Cognitive and Behavioral Practice},
Volume = {12},
Number = {2},
Pages = {198-208},
Publisher = {Elsevier BV},
Year = {2005},
Month = {January},
ISSN = {1077-7229},
url = {http://dx.doi.org/10.1016/S1077-7229(05)80025-2},
Abstract = {For the Treatment for Adolescents With Depression Study
(TADS), a cognitive-behavioral therapy (CBT) manual was
developed with the aim of balancing standardization and
flexibility. In this article, we describe the manual's case
formulation procedures, which served as one major mechanism
of flexibility in TADS CBT. We first describe the essential
components of a cognitive-behavioral case formulation. We
then present a rationale for including individualized case
formulation in manual-based treatments and clinical
effectiveness studies, and discuss the specific case of
TADS. We illustrate case formulation in an effectiveness
study with a composite "case" of a 15-year-old male treated
with TADS CBT Clinical implications and future directions
are discussed. Copyright © 2005 by Association for
Advancement of Behavior Therapy. All rights of reproduction
in any form reserved.},
Doi = {10.1016/S1077-7229(05)80025-2},
Key = {fds271765}
}
@article{fds271768,
Author = {Treatment for Adolescents and Depression Study (TADS)
Team},
Title = {The Treatment for Adolescents With Depression Study (TADS):
demographic and clinical characteristics.},
Journal = {Journal of the American Academy of Child and Adolescent
Psychiatry},
Volume = {44},
Number = {1},
Pages = {28-40},
Year = {2005},
Month = {January},
ISSN = {0890-8567},
url = {http://dx.doi.org/10.1097/01.chi.0000145807.09027.82},
Abstract = {OBJECTIVE: The Treatment for Adolescents With Depression
Study is a multicenter, randomized clinical trial sponsored
by the NIMH. This study is designed to evaluate the short-
and long-term effectiveness of four treatments for
adolescents with major depressive disorder: fluoxetine,
cognitive-behavioral therapy, their combination, and,
acutely, pill placebo. This report describes the demographic
and clinical characteristics of the sample and addresses
external validity. METHOD: Participants are 439 adolescents,
aged 12-17 years inclusively, with a primary DSM-IV
diagnosis of current major depressive disorder. Baseline
data are summarized and compared with those from national
samples and previous trials. RESULTS: The sample composition
is 54.4% girls, 73.8% white, 12.5% African American, and
8.9% Hispanic. The mean Child Depression Rating
Scale-Revised total score is 60.1 (SD = 10.4, range 45-98)
with 86.0% experiencing their first major depressive
episode. The most common concurrent diagnoses are
generalized anxiety disorder (15.3%), attention-deficit/hyperactivity
disorder (13.7%), oppositional defiant disorder (13.2%),
social phobia (10.7%), and dysthymia (10.5%). Demographic
results are consistent with data from national samples and
large psychopharmacology trials involving depressed
adolescents. CONCLUSIONS: The Treatment for Adolescents With
Depression Study provides a large, diverse, and
representative sample of depressed adolescents that
highlights the complexity of major depressive disorder in
adolescents and provides a rich source for explicating the
effects of moderator and mediator variables on baseline
psychopathology and treatment outcome.},
Doi = {10.1097/01.chi.0000145807.09027.82},
Key = {fds271768}
}
@article{fds271766,
Author = {Curry, JF and Wells, KC},
Title = {Striving for effectiveness in the treatment of adolescent
depression},
Journal = {Cognitive & Behavioral Practice},
Volume = {12},
Pages = {177-185},
Year = {2005},
Key = {fds271766}
}
@article{fds271771,
Author = {Compton, SN and March, JS and Brent, D and Albano, AM and Weersing, R and Curry, J},
Title = {Cognitive-behavioral psychotherapy for anxiety and
depressive disorders in children and adolescents: an
evidence-based medicine review.},
Journal = {Journal of the American Academy of Child and Adolescent
Psychiatry},
Volume = {43},
Number = {8},
Pages = {930-959},
Year = {2004},
Month = {August},
ISSN = {0890-8567},
url = {http://www.ncbi.nlm.nih.gov/pubmed/15266189},
Abstract = {OBJECTIVE: To review the literature on the
cognitive-behavioral treatment of children and adolescents
with anxiety and depressive disorders within the conceptual
framework of evidence-based medicine. METHOD: The
psychiatric and psychological literature was systematically
searched for controlled trials applying cognitive-behavioral
treatment to pediatric anxiety and depressive disorders.
RESULTS: For both anxiety and depression, substantial
evidence supports the efficacy of problem-specific
cognitive-behavioral interventions. Comparisons with
wait-list, inactive control, and active control conditions
suggest medium to large effects for symptom reduction in
primary outcome domains. CONCLUSIONS: From an evidence-based
perspective, cognitive-behavioral therapy is currently the
treatment of choice for anxiety and depressive disorders in
children and adolescents. Future research in this area will
need to focus on comparing cognitive-behavioral
psychotherapy with other treatments, component analyses, and
the application of exportable protocol-driven treatments to
divergent settings and patient populations.},
Doi = {10.1097/01.chi.0000127589.57468.bf},
Key = {fds271771}
}
@article{fds271800,
Author = {Hervey, AS and Epstein, JN and Curry, JF},
Title = {Neuropsychology of adults with attention-deficit/hyperactivity
disorder: a meta-analytic review.},
Journal = {Neuropsychology},
Volume = {18},
Number = {3},
Pages = {485-503},
Year = {2004},
Month = {July},
ISSN = {0894-4105},
url = {http://www.ncbi.nlm.nih.gov/pubmed/15291727},
Keywords = {Adult • Attention • Attention Deficit Disorder
with Hyperactivity • Humans • Inhibition
(Psychology) • Memory, Short-Term •
Neuropsychological Tests* • Psychomotor Performance
• Reaction Time • diagnosis* •
psychology},
Abstract = {A comprehensive, empirically based review of the published
studies addressing neuropsychological performance in adults
diagnosed with attention-deficit/hyperactivity disorder
(ADHD) was conducted to identify patterns of performance
deficits. Findings from 33 published studies were submitted
to a meta-analytic procedure producing sample-size-weighted
mean effect sizes across test measures. Results suggest that
neuropsychological deficits are expressed in adults with
ADHD across multiple domains of functioning, with notable
impairments in attention, behavioral inhibition, and memory,
whereas normal performance is noted in simple reaction time.
Theoretical and developmental considerations are discussed,
including the role of behavioral inhibition and working
memory impairment. Future directions for research based on
these findings are highlighted, including further
exploration of specific impairments and an emphasis on
particular tests and testing conditions.},
Doi = {10.1037/0894-4105.18.3.485},
Key = {fds271800}
}
@article{fds271799,
Author = {Curry, JF},
Title = {Future directions in residential treatment outcome
research.},
Journal = {Child and Adolescent Psychiatric Clinics of North
America},
Volume = {13},
Number = {2},
Pages = {429-440},
Year = {2004},
Month = {April},
ISSN = {1056-4993},
url = {http://www.ncbi.nlm.nih.gov/pubmed/15062355},
Keywords = {Adolescent • Child • Forecasting • Humans
• Mental Disorders • Residential Treatment •
Treatment Outcome • therapy* •
trends*},
Abstract = {Future outcome research on residential treatment will be
influenced positively by major trends in the helping
professions. These trends include the transfer of
empirically supported interventions into the residential
treatment setting, the targeting of specific problems or
disorders that burden children and adolescents,and more
sophisticated tests of positive and negative outcomes. It is
also likely that future research will use recent
developments in statistics that permit study of trajectories
of change in children or adolescents before, during, and
after residential treatment. Continued emphasis must be
placed on improving and studying postresidential
transitions, comparing residential to less restrictive
models of treatment, and qualitative investigations of
successful and unsuccessful cases.},
Doi = {10.1016/S1056-4993(03)00127-5},
Key = {fds271799}
}
@article{fds137878,
Title = {The Treatment for Adolescents with Depression Study (TADS)
Team. Fluoxetine, cognitive-behavioral therapy, and their
combination for adolescents with depression. Journal of the
American Medical Association, 2004, 292, 807-820.
| |
Duke University * Arts & Sciences * Faculty * Staff * Grad * Postdocs * Reload * Login | ||
